IndAS Details

Scrip Code	524804
NSE Symbol	AUROPHARMA
MSEI Symbol	NOTLISTED
ISIN	INE406A01037
Name of company	AUROBINDO PHARMA LIMITED
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-04-2025
Date of end of financial year	31-03-2026
Date of board meeting when results were approved	21-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	12-05-2026
Description of presentation currency	INR
Level of rounding used in financial results	Lakhs
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Standalone
Whether results are audited or unaudited for the quarter ended	Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Single segment
Description of single segment	Pharmaceutical products
Start date and time of board meeting	21-05-2026 16:30:00
End date and time of board meeting	21-05-2026 18:25:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Whether the company has any related party?	Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?	Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public	NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.	NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)?	No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?	Yes
Latest Date on which RPT policy is updated	09-02-2026
Indicate Company website link for updated RPT policy of the Company	https://www.aurobindo.com/investors/disclosures-under-regulation-46/policy-on-rpt
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter?	No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity?	No
No default on loan and no debt securities are issued.

Particulars	3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2026	01-04-2025
B	Date of end of reporting period	31-03-2026	31-03-2026
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
1	Income
	Revenue from operations	2,78,655.00	11,17,172.00
	Other income	21,409.00	58,753.00
	Total income	3,00,064.00	11,75,925.00
2	Expenses
(a)	Cost of materials consumed	1,25,166.00	5,23,838.00
(b)	Purchases of stock-in-trade	1,652.00	7,320.00
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	4,279.00	4,655.00
(d)	Employee benefit expense	29,271.00	1,16,115.00
(e)	Finance costs	4,727.00	21,315.00
(f)	Depreciation, depletion and amortisation expense	7,193.00	28,536.00
(f)	Other Expenses
1	Other expenses	40,145.00	1,56,050.00
	Total other expenses	40,145.00	1,56,050.00
	Total expenses	2,12,433.00	8,57,829.00
3	Total profit before exceptional items and tax	87,631.00	3,18,096.00
4	Exceptional items	0.00	(1,738.00)
5	Total profit before tax	87,631.00	3,16,358.00
6	Tax expense
7	Current tax	18,195.00	74,682.00
8	Deferred tax	213.00	196.00
9	Total tax expenses	18,408.00	74,878.00
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0.00	0.00
11	Net Profit Loss for the period from continuing operations	69,223.00	2,41,480.00
12	Profit (loss) from discontinued operations before tax	0.00	0.00
13	Tax expense of discontinued operations	0.00	0.00
14	Net profit (loss) from discontinued operation after tax	0.00	0.00
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0.00	0.00
16	Total profit (loss) for period	69,223.00	2,41,480.00
17	Other comprehensive income net of taxes	362.00	108.00
18	Total Comprehensive Income for the period	69,585.00	2,41,588.00
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent
	Total profit or loss, attributable to non-controlling interests
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent
	Total comprehensive income for the period attributable to owners of parent non-controlling interests
21	Details of equity share capital
	Paid-up equity share capital	5,808.00	5,808.00
	Face value of equity share capital	1	1
27	Details of debt securities
22	Reserves excluding revaluation reserve		22,65,961.00
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	11.92	41.58
	Diluted earnings (loss) per share from continuing operations	11.92	41.58
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	11.92	41.58
	Diluted earnings (loss) per share from continuing and discontinued operations	11.92	41.58
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results	Textual Information(1)

Textual Information(1)	1.The above standalone financial results of Aurobindo Pharma Limited (the Company) has been prepared in accordance with the Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 (the Act), read with the relevant rules issued thereunder and other accounting principles generally accepted in India and in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 2.The above standalone financial results of the Company as reviewed by the Audit Committee have been approved by the Board of Directors at its meeting held on May 21, 2026. The results for the year ended March 31, 2026 has been audited and for the quarter ended March 31, 2026 has been reviewed by our statutory auditors. The statutory auditors of the Company have expressed an unmodified opinion on the financial results for the year ended March 31, 2026 and have issued an unmodified conclusion in respect of the limited review for the quarter ended March 31, 2026. 3.The Company operates in only one reportable segment viz., 'Pharmaceuticals ' in accordance with Ind AS 108, Operating Segment. 4.On November 21, 2025, the Government of India notified provisions of the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, (‘Labour Codes’) which consolidate twenty-nine existing labour laws into a unified framework governing employee benefits during employment and post-employment. The Labour Codes, amongst other things introduces changes, including a uniform definition of wages and enhanced benefits relating to leave. The Company has assessed the financial implications of these changes which has resulted in increase in gratuity liability (arising out of past service cost) and increase in leave liability aggregating Rs.173.8 million. Considering the impact arising out of an enactment of the new legislation is an event of non-recurring nature, the Company has presented this incremental amount under “Exceptional Items” in the Standalone Statement of Profit and Loss for the quarter ended December 31, 2025 and year ended March 31, 2026. The Company continues to monitor the developments pertaining to Labour Codes and will evaluate impact if any on the measurement of liability pertaining to employee benefits. 5.The Board of Directors at their meeting held on April 06, 2026, approved buyback of 5,423,728 fully paid-up equity shares of face value of Rs.1 each (representing 0.93% of the total number of equity shares of the Company) for an aggregate value not exceeding Rs.8,000.0 million (Buyback Size) (excluding transaction cost) at a maximum buy back price of Rs. 1,475/- per equity share. The buyback offer is made to all of the equity shareholders of the Company, including the promoters and members of the promoter group of the Company (as defined under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011), who hold Equity Shares as of the record date (April 17, 2026), on proportionate basis through the tender offer route in accordance with the Companies Act, 2013, as amended, rules made thereunder, the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (Buyback Regulations) and other applicable laws. Pursuant to the buyback offer, 5,423,728 equity shares were accepted and consideration of Rs. 8,000.0 million was paid to eligible shareholders on May 07, 2026. 6.The Board of Directors of the Company at its meeting held on April 06, 2026 approved the transfer of domestic branded generic pharmaceutical formulations products business on a going concern basis through a Business Transfer Agreement (“BTA”) to Auropharm Limited (previously known as Auro Pharma Limited), a wholly owned subsidiary of the Company on a going concern basis by way of a slump sale w.e.f April 01, 2026 subject to certain conditions precedent including receipt of requisite approvals. 7.The figures for the current quarter and quarter ended March 31, 2025, are the balancing figures between the audited figures in respect of full financial year ended March 31, 2026 and March 31, 2025, respectively and published year to date figures up to third quarter ended December 31, 2025 and December 31, 2024, respectively, which were subject to limited review by the statutory auditors.

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Particulars	Year ended (dd-mm-yyyy)
Date of start of reporting period	01-04-2025
Date of end of reporting period	31-03-2026
Whether results are audited or unaudited	Audited
Nature of report standalone or consolidated	Standalone
	Assets
1	Non-current assets
	Property, plant and equipment	2,41,993.00
	Capital work-in-progress	22,855.00
	Investment property	0.00
	Goodwill	9,170.00
	Other intangible assets	3,210.00
	Intangible assets under development
	Biological assets other than bearer plants
	Investments accounted for using equity method
	Non-current financial assets
	Non-current investments	16,83,615.00
	Trade receivables, non-current	0.00
	Loans, non-current	1,21,045.00
	Other non-current financial assets
1	Other financial assets	4,904.00
	Total of other non-current financial assets	4,904.00
	Total non-current financial assets	18,09,564.00
	Deferred tax assets (net)	0.00
	Other non-current assets
1	Other non-current assets	9,937.00
2	Income tax assets (net)	29,021.00
	Total of other non-current assets	38,958.00
	Total non-current assets	21,25,750.00
2	Current assets
	Inventories	2,36,057.00
	Current financial asset
	Current investments	72,620.00
	Trade receivables, current	4,20,968.00
	Cash and cash equivalents	16,043.00
	Bank balance other than cash and cash equivalents	207.00
	Loans, current	569.00
	Other current financial assets
	Total of other current financial assets	323.00
	Total current financial assets	5,10,730.00
	Current tax assets (net)
	Other current assets
1	Other current assets	55,401.00
	Total of other current assets	55,401.00
	Total current assets	8,02,188.00
3	Non-current assets classified as held for sale
4	Regulatory deferral account debit balances and related deferred tax Assets
	Total assets	29,27,938.00
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	5,808.00
	Other equity	22,65,961.00
	Total equity attributable to owners of parent	22,71,769.00
	Non controlling interest
	Total equity	22,71,769.00
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0.00
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
	Total Trade payable
	Other non-current financial liabilities
1	Lease liabilities	8,541.00
	Total of other non-current financial liabilities	8,541.00
	Total non-current financial liabilities	8,541.00
	Provisions, non-current	7,317.00
	Deferred tax liabilities (net)	10,376.00
	Deferred government grants, Non-current
	Other non-current liabilities
	Total of other non-current liabilities
	Total non-current liabilities	26,234.00
	Current liabilities
	Current financial liabilities
	Borrowings, current	4,18,247.00
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	7,820.00
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	1,75,380.00
	Total Trade payable	1,83,200.00
	Other current financial liabilities
1	Lease liabilities	1,736.00
2	Other financial liabilities	14,797.00
	Total of other current financial liabilities	16,533.00
	Total current financial liabilities	6,17,980.00
	Other current liabilities	4,124.00
1	Other current liabilities	4,124.00
	Total of other current liabilities	4,124.00
	Provisions, current	2,458.00
	Current tax liabilities (Net)	5,373.00
	Deferred government grants, Current
	Total current liabilities	6,29,935.00
3	Liabilities directly associated with assets in disposal group classified as held for sale
4	Regulatory deferral account credit balances and related deferred tax liability
	Total liabilities	6,56,169.00
	Total equity and liabilites	29,27,938.00
	Disclosure of notes on assets and liabilities

Particulars	3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period	01-01-2026	01-04-2025
Date of end of reporting period	31-03-2026	31-03-2026
Whether results are audited or unaudited	Unaudited	Audited
Nature of report standalone or consolidated	Standalone	Standalone
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
	Total Segment Revenue
	Less: Inter segment revenue
	Revenue from operations
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
	Total Profit before tax
	i. Finance cost
	ii. Other Unallocable Expenditure net off Unallocable income
	Profit before tax
3	(Segment Asset - Segment Liabilities)
	Segment Asset
	Total Segment Asset
	Un-allocable Assets	null	null
	Net Segment Asset	null	null
4	Segment Liabilities
	Segment Liabilities
	Total Segment Liabilities
	Un-allocable Liabilities	null	null
	Net Segment Liabilities	null	null
	Disclosure of notes on segments

Particulars	3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-01-2026	01-04-2025
B	Date of end of reporting period	31-03-2026	31-03-2026
C	Whether results are audited or unaudited	Unaudited	Audited
D	Nature of report standalone or consolidated	Standalone	Standalone
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Re-measurement of defined benefit liability	484.00	145.00
	Total Amount of items that will not be reclassified to profit and loss	484.00	145.00
2	Income tax relating to items that will not be reclassified to profit or loss	122.00	37.00
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss
5	Total Other comprehensive income	362.00	108.00

Particulars	Year ended (dd-mm-yyyy)
A	Date of start of reporting period	01-04-2025
B	Date of end of reporting period	31-03-2026
C	Whether results are audited or unaudited	Audited
D	Nature of report standalone or consolidated	Standalone
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax	3,16,358.00
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs	21,173.00
	Adjustments for decrease (increase) in inventories	(128.00)
	Adjustments for decrease (increase) in trade receivables, current	22,300.00
	Adjustments for decrease (increase) in trade receivables, non-current	0.00
	Adjustments for decrease (increase) in other current assets	19,390.00
	Adjustments for decrease (increase) in other non-current assets	0.00
	Adjustments for other financial assets, non-current	0.00
	Adjustments for other financial assets, current	13,246.00
	Adjustments for other bank balances	0.00
	Adjustments for increase (decrease) in trade payables, current	995.00
	Adjustments for increase (decrease) in trade payables, non-current	0.00
	Adjustments for increase (decrease) in other current liabilities	1,220.00
	Adjustments for increase (decrease) in other non-current liabilities	0.00
	Adjustments for depreciation and amortisation expense	28,536.00
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss	0.00
	Adjustments for provisions, current	2,454.00
	Adjustments for provisions, non-current	0.00
	Adjustments for other financial liabilities, current	(13,117.00)
	Adjustments for other financial liabilities, non-current	0.00
	Adjustments for unrealised foreign exchange losses gains	(6,890.00)
	Adjustments for dividend income	23,008.00
	Adjustments for interest income	10,604.00
	Adjustments for share-based payments	0.00
	Adjustments for fair value losses (gains)	0.00
	Adjustments for undistributed profits of associates	0.00
	Other adjustments for which cash effects are investing or financing cash flow	(197.00)
	Other adjustments to reconcile profit (loss)	0.00
	Other adjustments for non-cash items	(1,645.00)
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships	0.00
	Total adjustments for reconcile profit (loss)	53,725.00
	Net cash flows from (used in) operations	3,70,083.00
	Dividends received	0.00
	Interest paid	0.00
	Interest received	0.00
	Income taxes paid (refund)	76,781.00
	Other inflows (outflows) of cash	0.00
	Net cash flows from (used in) operating activities	2,93,302.00
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses	0.00
	Cash flows used in obtaining control of subsidiaries or other businesses	0.00
	Other cash receipts from sales of equity or debt instruments of other entities	1,34,149.00
	Other cash payments to acquire equity or debt instruments of other entities	1,86,678.00
	Other cash receipts from sales of interests in joint ventures	0.00
	Other cash payments to acquire interests in joint ventures	0.00
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships	0.00
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships	0.00
	Proceeds from sales of property, plant and equipment	6,212.00
	Purchase of property, plant and equipment	52,061.00
	Proceeds from sales of investment property	0.00
	Purchase of investment property	0.00
	Proceeds from sales of intangible assets	0.00
	Purchase of intangible assets	0.00
	Proceeds from sales of intangible assets under development	0.00
	Purchase of intangible assets under development	0.00
	Proceeds from sales of goodwill	0.00
	Purchase of goodwill	0.00
	Proceeds from biological assets other than bearer plants	0.00
	Purchase of biological assets other than bearer plants	0.00
	Proceeds from government grants	0.00
	Proceeds from sales of other long-term assets	0.00
	Purchase of other long-term assets	0.00
	Cash advances and loans made to other parties	2,39,700.00
	Cash receipts from repayment of advances and loans made to other parties	88,010.00
	Cash payments for future contracts, forward contracts, option contracts and swap contracts	0.00
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts	0.00
	Dividends received	23,008.00
	Interest received	24,461.00
	Income taxes paid (refund)	0.00
	Other inflows (outflows) of cash	103.00
	Net cash flows from (used in) investing activities	(2,02,496.00)
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries	0.00
	Payments from changes in ownership interests in subsidiaries	0.00
	Proceeds from issuing shares	0.00
	Proceeds from issuing other equity instruments	0.00
	Payments to acquire or redeem entity's shares	0.00
	Payments of other equity instruments	0.00
	Proceeds from exercise of stock options	0.00
	Proceeds from issuing debentures notes bonds etc	0.00
	Proceeds from borrowings	18,000.00
	Repayments of borrowings	78,166.00
	Payments of lease liabilities	2,405.00
	Dividends paid	23,240.00
	Interest paid	21,424.00
	Income taxes paid (refund)	0.00
	Other inflows (outflows) of cash	0.00
	Net cash flows from (used in) financing activities	(1,07,235.00)
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes	(16,429.00)
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents	2,946.00
	Net increase (decrease) in cash and cash equivalents	(13,483.00)
	Cash and cash equivalents cash flow statement at beginning of period	29,526.00
	Cash and cash equivalents cash flow statement at end of period	16,043.00

Whether results are audited or unaudited	Audited
Declaration of unmodified opinion or statement on impact of audit qualification	Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results	Yes

Sr No.	Audit firm's name	Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI	Certificate valid upto
1	Deloitte Haskins & Sells	Yes	30-04-2028

	Name	Name	Relationship of the counterparty with the listed entity or its subsidiary	Type of related party transaction	Details of other related party transaction		Remarks on approval by audit committee			Value of transaction during the reporting period	Opening balance	Closing balance	Nature of indebtedness (loan/ issuance of debt/ any other etc.)	Details of other indebtedness	Nature (loan/ advance/ intercorporate deposit/ investment )	Notes
Sr No.														Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
	Details of the party (listed entity/subsidiary) entering into the transaction	Details of the counterparty		Type of related party transaction	Details of other related party transaction	Value of the related party transaction as approved by the audit committee	Remarks on approval by audit committee	Value of the related party transaction ratified by the audit committee	Date of Audit Committee Meeting where the ratification was approved	Value of transaction during the reporting period	In case monies are due to either party as a result of the transaction		In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments		Details of the loans, inter-corporate deposits, advances or investments	Notes
1	Aurobindo Pharma Limited	ACROTECH BIOPHARMA LLC	subsidiary	Purchase of goods or services			Nil			0.00	31.40	0.00
2	Aurobindo Pharma Limited	ALCEDO PHARMACHEM PRIVATE LIMITED	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		9,700.00	Nil			3,021.20	1,129.50	1,364.70
3	Aurobindo Pharma Limited	ALL PHARMA (SHANGHAI) TRADING CO.,LTD	subsidiary	Purchase of goods or services			Nil			20.90	258.70	268.40
4	Aurobindo Pharma Limited	Ambipack Industries, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Nil			0.00	0.00	0.00
5	Aurobindo Pharma Limited	APL HEALTH CARE LIMITED	subsidiary	Purchase of goods or services			Nil			406.60	22.30	205.50
6	Aurobindo Pharma Limited	APL Swift Services (Malta) Ltd.	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
7	Aurobindo Pharma Limited	ARROW GENERIQUES	subsidiary	Purchase of goods or services			Nil			4.90	0.00	5.10
8	Aurobindo Pharma Limited	AURO PEPTIDES LIMITED	subsidiary	Purchase of goods or services		2,000.00	Nil			578.00	292.60	0.00
9	Aurobindo Pharma Limited	AURO PHARMA INC	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
10	Aurobindo Pharma Limited	AURO PR INC	subsidiary	Purchase of goods or services			Nil			0.00	0.00	5.00
11	Aurobindo Pharma Limited	AUROBINDO PHARMA (ITALIA) SRL	subsidiary	Purchase of goods or services			Nil			1.30	0.00	0.00
12	Aurobindo Pharma Limited	Aurobindo Pharma (Malta) Limited	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
13	Aurobindo Pharma Limited	AUROBINDO PHARMA B.V.	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
14	Aurobindo Pharma Limited	AUROBINDO PHARMA COLOMBIA SAS	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
15	Aurobindo Pharma Limited	AUROBINDO PHARMA FZ LLC	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
16	Aurobindo Pharma Limited	AUROBINDO PHARMA JAPAN KK	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
17	Aurobindo Pharma Limited	AUROBINDO PHARMA PRODUTOS FARMACEUTICA LTDA	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
18	Aurobindo Pharma Limited	AUROBINDO PHARMA USA INC	subsidiary	Purchase of goods or services			Nil			87.00	58.40	3.30
19	Aurobindo Pharma Limited	Aurobindo Realty & Infrastructure Private Limited	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		700.00	Nil			0.00	0.00	0.00
20	Aurobindo Pharma Limited	AUROHEALTH LLC	subsidiary	Purchase of goods or services			Nil			0.00	17.90	0.00
21	Aurobindo Pharma Limited	AUROLIFE PHARMA LLC	subsidiary	Purchase of goods or services			Nil			188.10	201.10	347.30
22	Aurobindo Pharma Limited	AUROPRO SOFT SYSTEMS PVT. LTD	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		800.00	Nil			0.00	0.00	0.00
23	Aurobindo Pharma Limited	Aurovitas Pharma Polska Sp. z o.o.	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
24	Aurobindo Pharma Limited	Axis Clinicals LLC, USA	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		700.00	Nil			6.40	0.00	0.00
25	Aurobindo Pharma Limited	AXIS CLINICALS LTD, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		12,000.00	Nil			4,087.80	1,206.50	1,956.10
26	Aurobindo Pharma Limited	East Pharma Techonologies, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		1,200.00	Nil			531.40	80.10	164.00
27	Aurobindo Pharma Limited	EUGIA PHARMA INDUSTRIA FARMACEUTICA LIMITADA	subsidiary	Purchase of goods or services			Nil			0.00	12.60	13.40
28	Aurobindo Pharma Limited	EUGIA PHARMA SPECIALITIES LIMITED	subsidiary	Purchase of goods or services			Nil			403.70	3,830.30	403.30
29	Aurobindo Pharma Limited	Eugia SEZ Pvt.Ltd., (Wytells Pharma Pvt.Ltd.,)	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
30	Aurobindo Pharma Limited	Gelcaps Industries, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		11,000.00	Nil			4,304.50	1,303.70	2,856.50
31	Aurobindo Pharma Limited	GENERIS FARMACEUTICA SA	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
32	Aurobindo Pharma Limited	NVNR (Ramannapet I) Power Plant Private Limited, India	Associate Company	Purchase of goods or services		2,400.00	Nil			337.30	(15.50)	201.60
33	Aurobindo Pharma Limited	NVNR (Ramannapet II) Power Plant Private Limited, India	Associate Company	Purchase of goods or services		1,600.00	Nil			591.30	(42.50)	131.10
34	Aurobindo Pharma Limited	Orem Access Bio Inc, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		3,900.00	Nil			1,581.60	332.60	500.20
35	Aurobindo Pharma Limited	Pranit Packaging Private Limited, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		2,700.00	Nil			22.40	54.60	0.80
36	Aurobindo Pharma Limited	Sri Sai Packaging, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		2,950.00	Nil			1,208.30	279.20	279.90
37	Aurobindo Pharma Limited	Transaction Square LLP, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		100.00	Nil			53.30	0.00	16.30
38	Aurobindo Pharma Limited	AXIS CLINICALS LATINA, S.A. DE C.V. Total	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		300.00	Nil			0.00	0.00	0.00
39	Aurobindo Pharma Limited	AUROBINDO PHARMA INDUSTRIA FARMACEUTICA LTDA	subsidiary	Purchase of goods or services		20.00	Nil			0.00	26.90	28.80
40	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Purchase of goods or services			Nil			94,749.10	57,597.90	56,524.90
41	Aurobindo Pharma Limited	AUROVITAS PHARMA TAIZHOU CO. , LTD	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
42	Aurobindo Pharma Limited	AURO ENTERPRISES (INDIA) PRIVATE LIMITED	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		2,350.00	Nil			984.10	(155.90)	(189.40)
43	Aurobindo Pharma Limited	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Purchase of goods or services			Nil			8.50	0.00	8.70
44	Aurobindo Pharma Limited	AUROBINDO PHARMA (PTY) LTD	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
45	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
46	Aurobindo Pharma Limited	VALUCOR PACKAGING PRIVATE LIMITED	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		3,000.00	Nil			1,642.90	432.50	492.70
47	Aurobindo Pharma Limited	JETSETGO AVIATION SERVICES PRIVATE LIMITED	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		100.00	Nil			9.00	0.00	0.00
48	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Purchase of goods or services			Nil			0.00	0.00	0.00
49	Aurobindo Pharma Limited	SHREAS BIOLOGICALS PRIVATE LIMITED	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Nil			0.00	0.00	0.00
50	Aurobindo Pharma Limited	SHREAS INDUSTRIES LIMITED	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services		1,512.00	Nil			0.60	0.00	0.00
51	Aurobindo Pharma Limited	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Purchase of goods or services			Nil			3.20	0.00	0.00
52	Aurobindo Pharma Limited	Milpharm Limited	subsidiary	Purchase of goods or services			Nil			2.00	0.00	0.00
53	Aurobindo Pharma Limited	ACROTECH BIOPHARMA LLC	subsidiary	Sale of goods or services			Nil			0.00	0.60	0.00
54	Aurobindo Pharma Limited	APL HEALTH CARE LIMITED	subsidiary	Sale of goods or services			Nil			10,092.20	1,335.90	1,640.40
55	Aurobindo Pharma Limited	APL PHARMA THAI LTD	subsidiary	Sale of goods or services		4,935.00	Nil			598.50	56.80	231.10
56	Aurobindo Pharma Limited	APL Swift Services (Malta) Ltd.	subsidiary	Sale of goods or services			Nil			87,891.70	96,407.30	87,614.50
57	Aurobindo Pharma Limited	ARROW GENERIQUES	subsidiary	Sale of goods or services			Nil			39,211.30	22,447.40	23,969.40
58	Aurobindo Pharma Limited	AUREX B.V.	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
59	Aurobindo Pharma Limited	AURO PEPTIDES LIMITED	subsidiary	Sale of goods or services		1,000.00	Nil			318.70	11.90	64.80
60	Aurobindo Pharma Limited	AURO PHARMA INC	subsidiary	Sale of goods or services			Nil			30,138.30	34,066.10	35,882.60
61	Aurobindo Pharma Limited	AURO PR INC	subsidiary	Sale of goods or services			Nil			6.70	6.20	0.00
62	Aurobindo Pharma Limited	AURO VACCINES PRIVATE LIMITED	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
63	Aurobindo Pharma Limited	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Sale of goods or services			Nil			4.50	0.00	0.00
64	Aurobindo Pharma Limited	AUROBINDO NV	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
65	Aurobindo Pharma Limited	AUROBINDO PHARMA (ITALIA) SRL	subsidiary	Sale of goods or services			Nil			2.80	46.10	2.90
66	Aurobindo Pharma Limited	AUROBINDO PHARMA (MALTA) LTD	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
67	Aurobindo Pharma Limited	AUROBINDO PHARMA (PTY) LTD	subsidiary	Sale of goods or services			Nil			166.30	173.50	195.40
68	Aurobindo Pharma Limited	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Nil			4,911.50	3,288.90	3,501.10
69	Aurobindo Pharma Limited	AUROBINDO PHARMA COLOMBIA SAS	subsidiary	Sale of goods or services			Nil			1,035.90	950.50	1,114.70
70	Aurobindo Pharma Limited	AUROBINDO PHARMA FOUNDATION	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
71	Aurobindo Pharma Limited	AUROBINDO PHARMA FZ LLC	subsidiary	Sale of goods or services			Nil			305.80	90.50	389.70
72	Aurobindo Pharma Limited	Aurobindo Pharma Industria Farmaceut	subsidiary	Sale of goods or services			Nil			434.80	405.50	285.50
73	Aurobindo Pharma Limited	AUROBINDO PHARMA JAPAN KK	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
74	Aurobindo Pharma Limited	AUROBINDO PHARMA SAUDI ARABIA LIMITE	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
75	Aurobindo Pharma Limited	AUROBINDO PHARMA USA., INC	subsidiary	Sale of goods or services			Nil			1,78,039.50	1,37,311.60	1,31,603.10
76	Aurobindo Pharma Limited	AUROGEN SOUTH AFRICA (PTY) LTD	subsidiary	Sale of goods or services			Nil			1,834.60	2,027.90	1,185.00
77	Aurobindo Pharma Limited	AUROHEALTH LLC	subsidiary	Sale of goods or services			Nil			13,261.30	11,151.40	8,637.20
78	Aurobindo Pharma Limited	AUROLIFE PHARMA LLC	subsidiary	Sale of goods or services			Nil			3.20	7.20	11.20
79	Aurobindo Pharma Limited	AUROVIDA FARMACEUTICA, SA DE CV	subsidiary	Sale of goods or services			Nil			4,369.60	7,772.60	11,705.60
80	Aurobindo Pharma Limited	Aurovitas Pharma Polska Sp. z o.o.	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
81	Aurobindo Pharma Limited	AUROVITAS PHARMA TAIZHOU CO. , LTD	subsidiary	Sale of goods or services			Nil			346.30	172.50	554.70
82	Aurobindo Pharma Limited	AUROVITAS SPAIN S.A.U.	subsidiary	Sale of goods or services			Nil			559.20	44.50	587.60
83	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Sale of goods or services			Nil			0.00	0.00	12.30
84	Aurobindo Pharma Limited	EUGIA PHARMA (MALTA) LTD	subsidiary	Sale of goods or services			Nil			153.90	0.00	117.40
85	Aurobindo Pharma Limited	Eugia Pharma Industria Farmaceutica Limitada	subsidiary	Sale of goods or services			Nil			0.00	1,166.90	108.90
86	Aurobindo Pharma Limited	EUGIA PHARMA SPECIALITIES LIMITED	subsidiary	Sale of goods or services			Nil			9,439.40	10,275.10	14,942.00
87	Aurobindo Pharma Limited	EUGIA SEZ PRIVATE LIMITED	subsidiary	Sale of goods or services			Nil			1.50	74.20	0.20
88	Aurobindo Pharma Limited	EUGIA STERILES PRIVATE LIMITED	subsidiary	Sale of goods or services			Nil			4.50	0.70	1.50
89	Aurobindo Pharma Limited	EUGIA US LLC	subsidiary	Sale of goods or services			Nil			0.00	1,411.80	0.00
90	Aurobindo Pharma Limited	GENERIS FARMACEUTICA SA	subsidiary	Sale of goods or services			Nil			3,234.20	2,550.90	1,945.00
91	Aurobindo Pharma Limited	Giyaan Pharma Privated Limited, India	Enterprises over which key management personnel or their relatives exercise significant influence	Sale of goods or services		500.00	Nil			0.00	0.00	0.00
92	Aurobindo Pharma Limited	Luoxin Aurovitas Pharma(Chengdu) Co.,LTD	Joint ventures	Sale of goods or services			Nil			0.00	0.00	0.00
93	Aurobindo Pharma Limited	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Sale of goods or services			Nil			159.90	2.90	0.00
94	Aurobindo Pharma Limited	MILPHARM LIMITED	subsidiary	Sale of goods or services			Nil			14,255.30	16,336.10	11,338.30
95	Aurobindo Pharma Limited	NOVAGEN PHARMA (PTY) LTD	Joint ventures	Sale of goods or services			Nil			0.00	0.00	0.00
96	Aurobindo Pharma Limited	PHARMACIN B.V	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
97	Aurobindo Pharma Limited	Puren Pharma GmbH Co.Ltd.,	subsidiary	Sale of goods or services			Nil			0.00	0.00	0.00
98	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Sale of goods or services			Nil			366.30	336.60	0.00
99	Aurobindo Pharma Limited	Sri Sai Packaging, India	Enterprises over which key management personnel or their relatives exercise significant influence	Sale of goods or services		100.00	Nil			0.00	0.00	0.00
100	Aurobindo Pharma Limited	EUGIA PHARMA INC	subsidiary	Sale of goods or services			Nil			0.00	1,226.00	565.50
101	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Sale of goods or services			Nil			6,162.70	1,175.90	1,117.00
102	Aurobindo Pharma Limited	EUGIA PHARMA COLOMBIA SAS	subsidiary	Sale of goods or services			Nil			141.40	752.40	157.60
103	Aurobindo Pharma Limited	PT AUROGEN PHARMA INDONESIA	subsidiary	Sale of goods or services			Nil			121.70	43.10	25.90
104	Aurobindo Pharma Limited	VESPYR BRANDS LLC	subsidiary	Sale of goods or services			Nil			82.40	33.10	124.60
105	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Sale of PPE		Nil			0.00	0.00	0.00
106	Aurobindo Pharma Limited	APL HEALTH CARE LIMITED	subsidiary	Any other transaction	Sale of PPE		Nil			0.00	0.00	0.00
107	Aurobindo Pharma Limited	EUGIA PHARMA SPECIALITIES LIMITED	subsidiary	Any other transaction	Sale of PPE		Nil			0.00	0.00	0.00
108	Aurobindo Pharma Limited	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Sale of PPE		Nil			0.00	0.00	0.00
109	Aurobindo Pharma Limited	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Sale of PPE		Nil			0.00	0.00	0.00
110	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Sale of PPE		Nil			5.50	0.00	0.00
111	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	PLI Incentive		Nil			786.00	5,194.00	0.00
112	Aurobindo Pharma Limited	EUGIA PHARMA SPECIALITIES LIMITED	subsidiary	Any other transaction	PLI Incentive		Nil			1,220.00	3,455.00	0.00
113	Aurobindo Pharma Limited	APL HEALTH CARE LIMITED	subsidiary	Any other transaction	PLI Incentive		Nil			482.00	1,328.00	0.00
114	Aurobindo Pharma Limited	EUGIA SEZ PRIVATE LIMITED	subsidiary	Any other transaction	PLI Incentive		Nil			35.00	0.00	0.00
115	Aurobindo Pharma Limited	GLS Pharma Limited	subsidiary	Any other transaction	PLI Incentive		Nil			45.00	0.00	0.00
116	Aurobindo Pharma Limited	APL HEALTH CARE LIMITED	subsidiary	Any other transaction	Rent received		Nil			35.40	0.00	0.00
117	Aurobindo Pharma Limited	AURO PEPTIDES LIMITED	subsidiary	Any other transaction	Rent received	1,000.00	Nil			76.20	0.00	0.00
118	Aurobindo Pharma Limited	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Rent received		Nil			31.90	0.00	0.00
119	Aurobindo Pharma Limited	THERANYM BIOLOGICS PRIVATE LIMITED	subsidiary	Any other transaction	Rent received	80.00	Nil			12.70	0.00	0.00
120	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Rent received		Nil			1,042.20	0.00	0.00
121	Aurobindo Pharma Limited	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	collection of loan given including Interest		Nil			354.70	0.00	0.00
122	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	collection of loan given including Interest		Nil			320.30	0.00	0.00
123	Aurobindo Pharma Limited	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	collection of loan given including Interest		Nil			415.80	0.00	0.00
124	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	collection of loan given including Interest		Nil			0.00	0.00	0.00
125	Aurobindo Pharma Limited	EUGIA PHARMA SPECIALITIES LIMITED	subsidiary	Any other transaction	collection of loan given including Interest		Nil			18,249.90	0.00	0.00
126	Aurobindo Pharma Limited	AURO VACCINES PRIVATE LIMITED	subsidiary	Any other transaction	collection of loan given including Interest		Nil			0.00	0.00	0.00
127	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Any other transaction	collection of loan given including Interest		Nil			526.10	0.00	0.00
128	Aurobindo Pharma Limited	THERANYM BIOLOGICS PRIVATE LIMITED	subsidiary	Any other transaction	collection of loan given including Interest		Nil			0.00	0.00	0.00
129	Aurobindo Pharma Limited	EUGIA STERILES PRIVATE LIMITED	subsidiary	Any other transaction	collection of loan given including Interest		Nil			0.00	0.00	0.00
130	Aurobindo Pharma Limited	APL HEALTH CARE LIMITED	subsidiary	Any other transaction	Conversion of Debentures-CCD		Nil			0.00	0.00	0.00
131	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Conversion of Debentures-CCD		Nil			25,000.00	0.00	0.00
132	Aurobindo Pharma Limited	APL HEALTH CARE LIMITED	subsidiary	Any other transaction	Redemption of Debentures-OCD		Nil			0.00	0.00	0.00
133	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Redemption of Debentures-OCD		Nil			25,000.00	0.00	0.00
134	Aurobindo Pharma Limited	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Conversion of Debentures-CCD		Nil			0.00	0.00	0.00
135	Aurobindo Pharma Limited	Raidurgam Developers Limited	Joint ventures	Any other transaction	Redemption of Debentures-OCD		Nil			1,349.00	0.00	0.00
136	Aurobindo Pharma Limited	AUROBINDO PHARMA FOUNDATION	subsidiary	Any other transaction	Contribution towards CSR activities		Nil			2,715.10	0.00	0.00
137	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Any other transaction	Commission on Corporate Guarantee received		Nil			30.20	0.00	12.30
138	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Commission on Corporate Guarantee received		Nil			0.00	126.80	0.00
139	Aurobindo Pharma Limited	THERANYM BIOLOGICS PRIVATE LIMITED	subsidiary	Any other transaction	Commission on Corporate Guarantee received		Nil			44.30	0.00	0.00
140	Aurobindo Pharma Limited	AUROBINDO PHARMA FOUNDATION	subsidiary	Any other transaction	Commission on Corporate Guarantee received		Nil			0.00	98.70	0.00
141	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Any other transaction	Commission on Corporate Guarantee recivable		Nil			0.00	0.00	0.00
142	Aurobindo Pharma Limited	K. Nithyananda Reddy, Whole-time Director	Key managerial personnel	Any other transaction	Rent expenses (Receiving of services)	40.00	Nil			18.10	0.00	2.80
143	Aurobindo Pharma Limited	Raidurgam Developers Limited, India (JV)	Joint ventures	Any other transaction	Rent expenses including maintainance. & Deposit	3,900.00	Nil			1,685.40	0.00	49.20
144	Aurobindo Pharma Limited	APL HEALTH CARE LIMITED	subsidiary	Interest received			Nil			0.00	0.00	0.00
145	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Interest received			Nil			214.30	0.00	0.00
146	Aurobindo Pharma Limited	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Interest received			Nil			171.80	0.00	0.00
147	Aurobindo Pharma Limited	AURO VACCINES PRIVATE LIMITED	subsidiary	Interest received			Nil			10.40	0.00	0.00
148	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Interest received			Nil			37.30	0.00	0.00
149	Aurobindo Pharma Limited	Aurozest Private Limited	subsidiary	Interest received			Nil			2.60	0.00	0.00
150	Aurobindo Pharma Limited	GLS Pharma Limited	subsidiary	Interest received			Nil			95.30	0.00	0.00
151	Aurobindo Pharma Limited	Apitoria Pharma Private Limited	subsidiary	Interest received			Nil			189.90	0.00	0.00
152	Aurobindo Pharma Limited	Auroactive Pharma Private Limited	subsidiary	Interest received			Nil			26.00	0.00	0.00
153	Aurobindo Pharma Limited	Raidurgam Developers Limited, India	Joint ventures	Interest received			Nil			343.30	0.00	0.00
154	Aurobindo Pharma Limited	THERANYM BIOLOGICS PRIVATE LIMITED	subsidiary	Interest received			Nil			15.40	0.00	0.00
155	Aurobindo Pharma Limited	AURO VACCINES PRIVATE LIMITED	subsidiary	Interest received			Nil			249.50	0.00	0.00
156	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Interest received			Nil			834.80	0.00	0.00
157	Aurobindo Pharma Limited	EUGIA PHARMA SPECIALITIES LIMITED	subsidiary	Interest received			Nil			119.20	0.00	0.00
158	Aurobindo Pharma Limited	Eugia Sterile Pvt.Ltd., (Auro Cure Pvt.Ltd.,)	subsidiary	Interest received			Nil			0.00	0.00	0.00
159	Aurobindo Pharma Limited	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Interest received			Nil			352.30	0.00	0.00
160	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Interest received			Nil			562.80	0.00	0.00
161	Aurobindo Pharma Limited	Auroactive Pharma Private Limited	subsidiary	Interest received			Nil			236.10	0.00	0.00
162	Aurobindo Pharma Limited	Apitoria Pharma Private Limited	subsidiary	Interest received			Nil			0.00	0.00	0.00
163	Aurobindo Pharma Limited	THERANYM BIOLOGICS PRIVATE LIMITED	subsidiary	Interest received			Nil			292.40	0.00	0.00
164	Aurobindo Pharma Limited	GLS Pharma Limited	subsidiary	Interest received			Nil			55.50	0.00	0.00
165	Aurobindo Pharma Limited	AUROPHARM LIMITED (Formerly Known asAURO PHARMA LIMITED)	subsidiary	Interest received			Nil			591.80	0.00	0.00
166	Aurobindo Pharma Limited	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Loan			Nil			5,817.00	14,633.90	6,096.20
167	Aurobindo Pharma Limited	Eugia Sterile Pvt.Ltd., (Auro Cure Pvt.Ltd.,)	subsidiary	Loan			Nil			0.00	0.00	0.00
168	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Loan			Nil			20,706.50	14,332.60	20,718.80
169	Aurobindo Pharma Limited	EUGIA PHARMA SPECIALITIES LIMITED	subsidiary	Loan			Nil			107.30	18,142.60	0.00
170	Aurobindo Pharma Limited	AURO VACCINES PRIVATE LIMITED	subsidiary	Loan			Nil			2,224.50	5,524.80	7,749.40
171	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Loan			Nil			91,051.30	17,334.80	38,060.00
172	Aurobindo Pharma Limited	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Loan			Nil			5,212.50	10,354.40	5,151.40
173	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Loan			Nil			0.00	0.00	0.00
174	Aurobindo Pharma Limited	THERANYM BIOLOGICS PRIVATE LIMITED	subsidiary	Loan			Nil			263.20	8,509.80	8,773.00
175	Aurobindo Pharma Limited	GLS PHARMA LIMITED	subsidiary	Loan			Nil			350.00	1,222.90	1,572.90
176	Aurobindo Pharma Limited	AUROPHARM LIMITED (Formerly Known asAURO PHARMA LIMITED)	subsidiary	Loan			Nil			32,532.60	0.00	32,532.60
177	Aurobindo Pharma Limited	Auro Active Pharma Private Limited	subsidiary	Investment			Nil			0.00	0.00	0.00
178	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Investment			Nil			0.00	0.00	0.00
179	Aurobindo Pharma Limited	THERANYM BIOLOGICS PRIVATE LIMITED	subsidiary	Investment			Nil			0.00	0.00	0.00
180	Aurobindo Pharma Limited	GLS Pharma Limited	subsidiary	Investment			Nil			0.00	0.00	0.00
181	Aurobindo Pharma Limited	Tergene Boitech Pvt Ltd.	Joint ventures	Investment			Nil			0.00	0.00	0.00
182	Aurobindo Pharma Limited	AURO PEPTIDES LIMITED	subsidiary	Investment			Nil			1,800.00	0.00	0.00
183	Aurobindo Pharma Limited	Tergene Boitech Pvt Ltd.	Joint ventures	Investment			Nil			0.00	0.00	0.00
184	Aurobindo Pharma Limited	AURO PEPTIDES LIMITED	subsidiary	Investment			Nil			0.00	0.00	0.00
185	Aurobindo Pharma Limited	Tergene Boitech Pvt Ltd.	Joint ventures	Investment			Nil			0.00	0.00	0.00
186	Aurobindo Pharma Limited	AURO VACCINES PRIVATE LIMITED	subsidiary	Investment			Nil			0.00	0.00	0.00
187	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Investment			Nil			3,000.00	0.00	0.00
188	Aurobindo Pharma Limited	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Investment			Nil			0.00	0.00	0.00
189	Aurobindo Pharma Limited	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Investment			Nil			5,000.00	0.00	0.00
190	Aurobindo Pharma Limited	GLS Pharma Limited	subsidiary	Investment			Nil			0.00	0.00	0.00
191	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Investment			Nil			0.00	0.00	0.00
192	Aurobindo Pharma Limited	THERANYM BIOLOGICS PRIVATE LIMITED	subsidiary	Investment			Nil			1,600.00	0.00	0.00
193	Aurobindo Pharma Limited	NVNR (Ramannapet I) Power Plant Private Limited, India	Associate Company	Investment			Nil			0.00	0.00	0.00
194	Aurobindo Pharma Limited	NVNR (Ramannapet II) Power Plant Private Limited, India	Associate Company	Investment			Nil			0.00	0.00	0.00
195	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Any other transaction	Sale of-CCD In AURO VACCINES PRIVATE LIMITED		Nil			52,800.00	0.00	0.00
196	Aurobindo Pharma Limited	GLS Pharma Limited	subsidiary	Investment			Nil			0.00	0.00	0.00
197	Aurobindo Pharma Limited	APL HEALTH CARE LIMITED	subsidiary	Investment			Nil			0.00	0.00	0.00
198	Aurobindo Pharma Limited	APITORIA PHARMA PRIVATE LIMITED	subsidiary	Investment			Nil			0.00	0.00	0.00
199	Aurobindo Pharma Limited	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Conversion of Loan into CCD		Nil			14,000.00	0.00	0.00
200	Aurobindo Pharma Limited	QULE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Conversion of Loan into CCD		Nil			14,000.00	0.00	0.00
201	Aurobindo Pharma Limited	CURATEQ BIOLOGICS PRIVATE LIMITED	subsidiary	Any other transaction	Conversion of Loan into CCD		Nil			69,800.00	0.00	0.00
202	Aurobindo Pharma Limited	THERANYM BIOLOGICS PRIVATE LIMITED	subsidiary	Any other transaction	Conversion of Loan into CCD		Nil			0.00	0.00	0.00
203	Aurobindo Pharma Limited	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Conversion of Loan into CCD		Nil			10,000.00	0.00	0.00
204	Aurobindo Pharma Limited	K. Nithyananda Reddy, Whole-time Director	Key managerial personnel	Remuneration			Nil			245.00	0.00	0.00
205	Aurobindo Pharma Limited	P SARATH CHANDRA REDDY	Key managerial personnel	Remuneration			Nil			4.00	0.00	0.00
206	Aurobindo Pharma Limited	PENAKA VENKATA RAMA PRASAD REDDY	Key managerial personnel	Remuneration			Nil			2.00	0.00	0.00
207	Aurobindo Pharma Limited	Mr. M. Madan Mohan Reddy, Whole-time Director	Key managerial personnel	Remuneration			Nil			312.60	0.00	0.00
208	Aurobindo Pharma Limited	Mr. Santhanam Subramanian, Chief Financial Officer	Key managerial personnel	Remuneration			Nil			231.50	0.00	0.00
209	Aurobindo Pharma Limited	Mr. B. Adi Reddy, Company Secretary	Key managerial personnel	Remuneration			Nil			44.30	0.00	0.00
210	Aurobindo Pharma Limited	AUROBINDO PHARMA INDUSTRIA FARMACEUTICA LTDA	subsidiary	Dividend received			Nil			7,056.20	0.00	0.00
211	Aurobindo Pharma Limited	HELIX HEALTHCARE BV	subsidiary	Dividend received			Nil			15,952.10	0.00	0.00
212	Helix Healthcare B.V.	Agile Pharma B.V.	subsidiary	Interest received			Not Applicable			434.20	6,992.40	124.40
213	Helix Healthcare B.V.	Agile Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	30,576.90	23,226.80
214	Helix Healthcare B.V.	Milpharm Limited	subsidiary	Interest received			Not Applicable			313.00	83.50	39.50
215	Helix Healthcare B.V.	Milpharm Limited	subsidiary	Loan			Not Applicable			0.00	22,200.20	5,518.60
216	Helix Healthcare B.V.	Aurovida Farmaceutica SA DE CV	subsidiary	Interest received			Not Applicable			4.20	894.80	0.00
217	Helix Healthcare B.V.	Aurovida Farmaceutica SA DE CV	subsidiary	Loan			Not Applicable			0.00	5,952.10	0.00
218	Helix Healthcare B.V.	Aurovitas Pharma (Taizhou) Ltd	subsidiary	Interest received			Not Applicable			284.70	4,063.90	4,646.00
219	Helix Healthcare B.V.	Aurovitas Pharma (Taizhou) Ltd	subsidiary	Loan			Not Applicable			0.00	10,216.40	10,927.10
220	Helix Healthcare B.V.	Aurosalud SA De CV	subsidiary	Loan			Not Applicable			0.00	0.00	6,366.20
221	Helix Healthcare B.V.	Aurosalud SA De CV	subsidiary	Interest received			Not Applicable			167.00	0.00	1,136.90
222	Helix Healthcare B.V.	PT Aurogen Pharma Indonesia	subsidiary	Loan			Not Applicable			0.00	0.00	3,563.20
223	Helix Healthcare B.V.	PT Aurogen Pharma Indonesia	subsidiary	Interest received			Not Applicable			9.50	0.00	10.10
224	Helix Healthcare B.V.	Auro PR Inc	subsidiary	Interest received			Not Applicable			51.20	4.30	60.10
225	Helix Healthcare B.V.	Auro PR Inc	subsidiary	Loan			Not Applicable			0.00	444.20	3,325.60
226	Helix Healthcare B.V.	Aurobindo Pharma Japan KK	subsidiary	Dividend received			Not Applicable			24.70	0.00	0.00
227	Helix Healthcare B.V.	Aurobindo Pharma B.V.	subsidiary	Interest received			Not Applicable			27.60	0.00	0.00
228	Helix Healthcare B.V.	Aurobindo Pharma B.V.	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	778.10	498.80
229	Agile Pharma B.V.	Puren Pharma GmbH & Co., KG	subsidiary	Dividend received			Not Applicable			332.60	0.00	0.00
230	Agile Pharma B.V.	Aurobindo Pharma B.V.	subsidiary	Interest received			Not Applicable			3.00	0.30	0.10
231	Agile Pharma B.V.	Aurobindo Pharma B.V.	subsidiary	Dividend received			Not Applicable			11,608.00	0.00	0.00
232	Agile Pharma B.V.	Aurobindo Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	313.00	327.00
233	Agile Pharma B.V.	CuraTeQ Biologics B.V., Netherlands	subsidiary	Interest received			Not Applicable			0.30	0.30	0.00
234	Agile Pharma B.V.	CuraTeQ Biologics B.V., Netherlands	subsidiary	Loan			Not Applicable			0.00	104.30	0.00
235	Agile Pharma B.V.	CuraTeQ Biologics s.r.o.	subsidiary	Loan			Not Applicable			0.00	0.00	196.20
236	Agile Pharma B.V.	CuraTeQ Biologics s.r.o.	subsidiary	Interest received			Not Applicable			1.20	0.00	1.30
237	Agile Pharma B.V.	Aurobindo Pharma (Malta) Ltd	subsidiary	Dividend received			Not Applicable			11,155.80	0.00	0.00
238	Milpharm Limited	Eugia Pharma (Malta) Limited	subsidiary	Sale of goods or services			Not Applicable			283.40	51.00	46.70
239	Milpharm Limited	CuraTeQ Biologics s.r.o.	subsidiary	Sale of goods or services			Not Applicable			138.10	111.30	260.60
240	Milpharm Limited	Eugia (UK) Limited	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	84.10	0.00
241	Milpharm Limited	Ace Laboratories Limited	subsidiary	Any other transaction	Trade Receivable		Not Applicable			0.00	0.60	0.00
242	Milpharm Limited	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			293.30	121.30	111.90
243	Milpharm Limited	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Not Applicable			377.00	73.70	146.70
244	Milpharm Limited	Puren Pharma GmbH & Co., KG	subsidiary	Sale of goods or services			Not Applicable			296.10	61.80	50.70
245	Milpharm Limited	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			670.50	142.10	844.70
246	Milpharm Limited	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			503.00	110.10	97.40
247	Milpharm Limited	Generis Farmaceutica S.A.	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	277.90	0.00
248	Milpharm Limited	Aurobindo Pharma (Italia) S.r.l	subsidiary	Sale of goods or services			Not Applicable			201.40	77.60	74.30
249	Milpharm Limited	Aurovitas Spol s.r.o	subsidiary	Sale of goods or services			Not Applicable			0.00	0.20	0.00
250	Milpharm Limited	Aurovitas Pharma Polska	subsidiary	Sale of goods or services			Not Applicable			184.60	42.80	35.90
251	Milpharm Limited	Aurobindo NV/SA	subsidiary	Sale of goods or services			Not Applicable			108.80	22.40	13.10
252	Milpharm Limited	APL Swift Services (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			330.20	20.20	14.60
253	Milpharm Limited	CuraTeQ Biologics Private Limited	subsidiary	Sale of goods or services			Not Applicable			1.50	1.20	1.50
254	Milpharm Limited	Helix Healthcare B.V.	subsidiary	Interest received			Not Applicable			1.10	0.00	0.00
255	Milpharm Limited	Agile Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	0.00	753.10
256	Milpharm Limited	Agile Pharma B.V.	subsidiary	Interest received			Not Applicable			16.10	0.00	17.10
257	APL Swift Services (Malta) Ltd	Eugia Pharma (Malta) Limited	subsidiary	Sale of goods or services			Not Applicable			1,361.90	537.30	233.30
258	APL Swift Services (Malta) Ltd	Eugia Pharma (Malta) Limited	subsidiary	Any other transaction	other income		Not Applicable			13.50	0.00	0.00
259	APL Swift Services (Malta) Ltd	Eugia Pharma (Malta) Limited	subsidiary	Interest received			Not Applicable			0.00	0.20	0.20
260	APL Swift Services (Malta) Ltd	Eugia SEZ Private Limited	subsidiary	Any other transaction	Trade Receivable		Not Applicable			0.00	48.00	0.00
261	APL Swift Services (Malta) Ltd	Aurobindo Pharma (Italia) S.r.l	subsidiary	Sale of goods or services			Not Applicable			5,165.70	4,432.60	3,263.20
262	APL Swift Services (Malta) Ltd	Aurovitas Pharma Polska	subsidiary	Sale of goods or services			Not Applicable			9,895.00	1,286.50	3,539.50
263	APL Swift Services (Malta) Ltd	Aurobindo NV/SA	subsidiary	Sale of goods or services			Not Applicable			5,932.80	1,556.40	2,318.30
264	APL Swift Services (Malta) Ltd	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			5,790.60	4,189.10	3,711.40
265	APL Swift Services (Malta) Ltd	Puren Pharma GmbH & Co., KG	subsidiary	Sale of goods or services			Not Applicable			25,427.20	4,486.70	0.00
266	APL Swift Services (Malta) Ltd	Puren Pharma GmbH & Co., KG	subsidiary	Interest received			Not Applicable			33.00	15.30	5.00
267	APL Swift Services (Malta) Ltd	Puren Pharma GmbH & Co., KG	subsidiary	Loan			Not Applicable			0.00	3,978.20	439.50
268	APL Swift Services (Malta) Ltd	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			10,888.00	5,334.80	3,257.00
269	APL Swift Services (Malta) Ltd	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Not Applicable			25,975.40	12,237.20	5,450.60
270	APL Swift Services (Malta) Ltd	Aurobindo Pharma B.V.	subsidiary	Interest received			Not Applicable			22.60	0.00	13.00
271	APL Swift Services (Malta) Ltd	Aurobindo Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	0.00	10,899.50
272	APL Swift Services (Malta) Ltd	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			16,087.60	3,414.90	8,863.80
273	APL Swift Services (Malta) Ltd	Auro Pharma Inc.	subsidiary	Sale of goods or services			Not Applicable			121.90	179.10	58.40
274	APL Swift Services (Malta) Ltd	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			1,876.30	529.40	761.40
275	APL Swift Services (Malta) Ltd	Milpharm Limited	subsidiary	Interest received			Not Applicable			50.00	0.00	38.90
276	APL Swift Services (Malta) Ltd	Milpharm Limited	subsidiary	Loan			Not Applicable			0.00	0.00	4,001.70
277	APL Swift Services (Malta) Ltd	Agile Pharma B.V.	subsidiary	Interest received			Not Applicable			103.40	149.60	10.80
278	APL Swift Services (Malta) Ltd	Agile Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	9,910.60	1,307.90
279	APL Swift Services (Malta) Ltd	Aurobindo Pharma (Malta) Ltd	subsidiary	Any other transaction	Miscellaneous Income		Not Applicable			0.40	2.90	0.00
280	APL Swift Services (Malta) Ltd	Aurobindo Pharma (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			14.60	0.00	21.70
281	APL Swift Services (Malta) Ltd	CuraTeQ Biologics Private Limited	subsidiary	Sale of goods or services			Not Applicable			0.00	25.30	26.40
282	APL Swift Services (Malta) Ltd	CuraTeQ Biologics s.r.o.	subsidiary	Sale of goods or services			Not Applicable			81.70	0.00	87.00
283	APL Swift Services (Malta) Ltd	CuraTeQ Biologics B.V., Netherlands	subsidiary	Any other transaction	other income		Not Applicable			0.20	0.00	0.20
284	APL Swift Services (Malta) Ltd	CuraTeQ Biologics (Malta) Limited	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	0.00	340.80
285	APL Swift Services (Malta) Ltd	Eugia Pharma B.V.	subsidiary	Any other transaction	other income		Not Applicable			0.50	0.00	0.60
286	APL Swift Services (Malta) Ltd	Aurovitas Pharma (Taizhou) Ltd	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	1,304.00	508.50
287	Aurobindo Pharma (Malta) Ltd	Aurovitas Pharma Polska	subsidiary	Sale of goods or services			Not Applicable			2.00	0.00	0.00
288	Aurobindo Pharma (Malta) Ltd	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			1.80	16.00	0.00
289	Aurobindo Pharma (Malta) Ltd	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			8.10	66.10	25.60
290	Aurobindo Pharma (Malta) Ltd	APL Swift Services (Malta) Ltd	subsidiary	Interest received			Not Applicable			7.60	125.60	138.90
291	Aurobindo Pharma (Malta) Ltd	APL Swift Services (Malta) Ltd	subsidiary	Dividend received			Not Applicable			1,867.80	7,526.30	1,987.40
292	Aurobindo Pharma (Malta) Ltd	APL Swift Services (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			203.20	26.50	43.30
293	Aurobindo Pharma (Malta) Ltd	APL Swift Services (Malta) Ltd	subsidiary	Loan			Not Applicable			0.00	1,674.40	337.90
294	Aurobindo Pharma (Malta) Ltd	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Not Applicable			1.30	0.00	0.00
295	Aurobindo Pharma (Malta) Ltd	Aurobindo Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	2,656.70	0.00
296	Aurobindo Pharma (Malta) Ltd	Aurobindo Pharma B.V.	subsidiary	Interest received			Not Applicable			25.40	5.80	0.00
297	Aurobindo Pharma (Malta) Ltd	Aurobindo NV/SA	subsidiary	Sale of goods or services			Not Applicable			6.80	1.90	0.00
298	Aurobindo Pharma (Malta) Ltd	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			1.80	1.40	0.00
299	Aurobindo Pharma (Malta) Ltd	Eugia Pharma (Malta) Limited	subsidiary	Sale of goods or services			Not Applicable			10.40	0.00	1.80
300	Aurobindo Pharma (Malta) Ltd	Puren Pharma GmbH & Co., KG	subsidiary	Sale of goods or services			Not Applicable			24.30	14.60	2.60
301	Aurobindo Pharma (Malta) Ltd	Puren Pharma GmbH & Co., KG	subsidiary	Interest received			Not Applicable			1.20	0.20	0.80
302	Aurobindo Pharma (Malta) Ltd	Puren Pharma GmbH & Co., KG	subsidiary	Loan			Not Applicable			0.00	65.80	69.10
303	Aurobindo Pharma (Malta) Ltd	Aurobindo Pharma (Italia) S.r.l	subsidiary	Sale of goods or services			Not Applicable			8.70	0.00	0.00
304	Aurovitas Pharma Polska	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			5.10	0.90	5.30
305	Aurovitas Pharma Polska	Eugia Pharma (Malta) Limited	subsidiary	Sale of goods or services			Not Applicable			0.00	30.00	11.40
306	Aurovitas Pharma Polska	Eugia Pharma (Malta) Limited	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			91.00	0.00	0.00
307	Aurovitas Pharma Polska	Aurobindo NV/SA	subsidiary	Sale of goods or services			Not Applicable			12.80	5.00	6.30
308	Aurovitas Pharma Polska	Puren Pharma GmbH & Co., KG	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			16.30	5.40	0.00
309	Aurovitas Pharma Polska	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			3.30	2.60	5.10
310	Aurovitas Pharma Polska	Aurovitas Spain SA	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			12.50	0.00	0.00
311	Aurovitas Pharma Polska	Aurobindo Pharma B.V.	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.20	0.00	0.00
312	Aurovitas Pharma Polska	Aurobindo Pharma (Italia) S.r.l	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.20	0.00	0.00
313	Aurovitas Pharma Polska	Apotex Europe B.V.	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			(14.10)	0.00	0.00
314	Generis Farmaceutica S.A.	Eugia Pharma (Malta) Limited	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			136.00	7.40	0.00
315	Generis Farmaceutica S.A.	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			231.40	0.00	290.90
316	Generis Farmaceutica S.A.	Milpharm Limited	subsidiary	Interest received			Not Applicable			210.60	46.10	145.60
317	Generis Farmaceutica S.A.	Milpharm Limited	subsidiary	Any other transaction	other income		Not Applicable			9.20	0.00	0.00
318	Generis Farmaceutica S.A.	Milpharm Limited	subsidiary	Loan			Not Applicable			0.00	11,067.70	11,807.40
319	Generis Farmaceutica S.A.	APL Swift Services (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			4.80	1.10	0.30
320	Generis Farmaceutica S.A.	APL Swift Services (Malta) Ltd	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.40	0.00	0.00
321	Generis Farmaceutica S.A.	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Not Applicable			2,134.30	283.60	593.70
322	Generis Farmaceutica S.A.	Aurobindo Pharma B.V.	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			160.70	0.00	0.00
323	Generis Farmaceutica S.A.	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			3,072.10	888.10	1,236.50
324	Generis Farmaceutica S.A.	Arrow generiques SAS	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			19.40	0.00	0.10
325	Generis Farmaceutica S.A.	Puren Pharma GmbH & Co., KG	subsidiary	Sale of goods or services			Not Applicable			1,022.30	450.60	318.00
326	Generis Farmaceutica S.A.	Puren Pharma GmbH & Co., KG	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			45.90	0.00	0.00
327	Generis Farmaceutica S.A.	Puren Pharma GmbH & Co., KG	subsidiary	Interest received			Not Applicable			0.20	0.00	0.00
328	Generis Farmaceutica S.A.	Aurovitas Spain SA	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			56.00	0.00	0.00
329	Generis Farmaceutica S.A.	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			887.10	45.00	44.00
330	Generis Farmaceutica S.A.	Aurovitas Pharma Polska	subsidiary	Sale of goods or services			Not Applicable			118.70	17.00	6.00
331	Generis Farmaceutica S.A.	Aurovitas Pharma Polska	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			32.10	0.00	0.00
332	Generis Farmaceutica S.A.	Aurobindo Pharma (Italia) S.r.l	subsidiary	Sale of goods or services			Not Applicable			335.20	25.50	48.70
333	Generis Farmaceutica S.A.	Aurobindo Pharma (Italia) S.r.l	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			63.10	0.00	0.00
334	Generis Farmaceutica S.A.	Aurobindo NV/SA	subsidiary	Sale of goods or services			Not Applicable			257.00	69.30	171.00
335	Generis Farmaceutica S.A.	Aurobindo NV/SA	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			42.30	0.00	0.00
336	Generis Farmaceutica S.A.	Aurobindo Pharma (Malta) Ltd	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			4.70	0.00	0.00
337	Generis Farmaceutica S.A.	Aurobindo Pharma (Malta) Ltd	subsidiary	Any other transaction	Trade Receivable		Not Applicable			0.00	29.50	0.00
338	Generis Farmaceutica S.A.	APL Healthcare Limited	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			21.50	0.00	22.90
339	Aurobindo Pharma (Italia) S.r.l	Eugia SEZ Private Limited	subsidiary	Sale of goods or services			Not Applicable			1.30	0.00	1.40
340	Aurobindo Pharma (Italia) S.r.l	Eugia Pharma (Malta) Limited	subsidiary	Sale of goods or services			Not Applicable			644.50	46.20	179.50
341	Aurobindo Pharma (Italia) S.r.l	Eugia Pharma (Malta) Limited	subsidiary	Any other transaction	Miscellaneous Income		Not Applicable			6.60	0.00	0.00
342	Aurobindo Pharma (Italia) S.r.l	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			12.70	0.00	4.00
343	Aurobindo Pharma (Italia) S.r.l	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			7.50	0.40	0.50
344	Aurobindo Pharma (Italia) S.r.l	Eugia Pharma Specialities Ltd	subsidiary	Sale of goods or services			Not Applicable			17.20	15.80	34.50
345	Aurobindo Pharma (Italia) S.r.l	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Not Applicable			2.80	2.10	0.00
346	Aurobindo Pharma (Italia) S.r.l	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			2.70	1.80	1.90
347	Aurobindo Pharma (Italia) S.r.l	Puren Pharma GmbH & Co., KG	subsidiary	Sale of goods or services			Not Applicable			7.80	3.60	0.00
348	Aurobindo Pharma (Italia) S.r.l	APL Swift Services (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			4.90	0.00	0.20
349	Aurobindo Pharma (Italia) S.r.l	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			8.20	0.00	0.00
350	Aurobindo Pharma (Italia) S.r.l	Aurobindo Pharma (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			2.10	0.00	0.00
351	Aurobindo Pharma (Italia) S.r.l	Aurovitas Pharma Polska	subsidiary	Sale of goods or services			Not Applicable			2.10	0.00	0.00
352	Arrow generiques SAS	Aurovitas Pharma Polska	subsidiary	Sale of goods or services			Not Applicable			328.70	0.00	132.20
353	Arrow generiques SAS	Agile Pharma B.V.	subsidiary	Interest received			Not Applicable			134.10	173.10	15.80
354	Arrow generiques SAS	Agile Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	11,475.50	6,539.70
355	Arrow generiques SAS	Eugia Pharma (Malta) Limited	subsidiary	Sale of goods or services			Not Applicable			2.60	0.00	639.10
356	Arrow generiques SAS	Eugia Pharma (Malta) Limited	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			599.60	0.00	0.00
357	Arrow generiques SAS	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			313.30	0.00	0.00
358	Arrow generiques SAS	Aurobindo Pharma (Italia) S.r.l	subsidiary	Sale of goods or services			Not Applicable			147.30	0.00	10.50
359	Arrow generiques SAS	Aurobindo NV/SA	subsidiary	Sale of goods or services			Not Applicable			21.40	3.80	5.50
360	Arrow generiques SAS	Puren Pharma GmbH & Co., KG	subsidiary	Sale of goods or services			Not Applicable			294.50	0.00	26.20
361	Arrow generiques SAS	Puren Pharma GmbH & Co., KG	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			(0.60)	0.00	0.00
362	Arrow generiques SAS	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			834.30	0.00	0.00
363	Arrow generiques SAS	Aurovitas Spain SA	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			37.70	0.00	0.00
364	Arrow generiques SAS	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Not Applicable			77.70	0.00	6.40
365	Arrow generiques SAS	Aurobindo Pharma B.V.	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			16.20	0.00	0.00
366	Diadame Pharma	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			221.30	0.00	175.20
367	Puren Pharma GmbH & Co., KG	Agile Pharma B.V.	subsidiary	Interest received			Not Applicable			435.60	90.20	75.60
368	Puren Pharma GmbH & Co., KG	Agile Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	29,731.90	31,063.60
369	Puren Pharma GmbH & Co., KG	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Not Applicable			0.10	0.00	0.00
370	Puren Pharma GmbH & Co., KG	Aurobindo Pharma (Italia) S.r.l	subsidiary	Sale of goods or services			Not Applicable			1.80	0.50	0.00
371	Puren Pharma GmbH & Co., KG	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			88.20	238.50	37.40
372	Puren Pharma GmbH & Co., KG	Milpharm Limited	subsidiary	Interest received			Not Applicable			139.80	20.50	44.40
373	Puren Pharma GmbH & Co., KG	Milpharm Limited	subsidiary	Loan			Not Applicable			0.00	4,696.60	8,866.30
374	Puren Pharma GmbH & Co., KG	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			0.10	3.30	0.00
375	Puren Pharma GmbH & Co., KG	APL Swift Services (Malta) Ltd	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	0.00	11,772.40
376	Puren Pharma GmbH & Co., KG	APL Swift Services (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			48.60	7.90	11.60
377	Puren Pharma GmbH & Co., KG	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			48.50	5.40	0.00
378	Puren Pharma GmbH & Co., KG	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			0.10	3.30	3.50
379	1980 Puren Pharma GmbH	Puren Pharma GmbH & Co., KG	subsidiary	Any other transaction	Miscellaneous Income		Not Applicable			12.10	0.00	12.90
380	Aurovitas Spain SA	Eugia Pharma (Malta) Limited	subsidiary	Sale of goods or services			Not Applicable			266.80	20.00	3.80
381	Aurovitas Spain SA	Agile Pharma B.V.	subsidiary	Interest received			Not Applicable			98.40	103.00	17.20
382	Aurovitas Spain SA	Agile Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	6,781.00	7,084.70
383	Aurovitas Spain SA	APL Swift Services (Malta) Ltd	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.00	1.60	0.00
384	Aurovitas Spain SA	Aurobindo Pharma (Italia) S.r.l	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.70	0.00	0.00
385	Aurovitas Spain SA	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			0.50	0.00	0.00
386	Aurovitas Spain SA	Arrow generiques SAS	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	0.00	58.40
387	Aurobindo Pharma B.V.	Aurovitas Spain SA	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			1.10	0.00	0.00
388	Aurobindo Pharma B.V.	APL Swift Services (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			15.40	28.20	10.40
389	Aurobindo Pharma B.V.	APL Swift Services (Malta) Ltd	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			64.70	0.00	0.00
390	Aurobindo Pharma B.V.	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			158.20	0.70	65.00
391	Aurobindo Pharma B.V.	Generis Farmaceutica S.A.	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.00	0.00	0.00
392	Aurobindo Pharma B.V.	Helix Healthcare B.V.	subsidiary	Loan			Not Applicable			0.00	0.00	1,984.40
393	Aurobindo Pharma B.V.	Helix Healthcare B.V.	subsidiary	Interest received			Not Applicable			15.90	0.00	16.80
394	Aurobindo Pharma B.V.	Aurobindo NV/SA	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.00	0.00	0.00
395	Aurobindo Pharma B.V.	Milpharm Limited	subsidiary	Loan			Not Applicable			0.00	5,216.10	6,927.40
396	Aurobindo Pharma B.V.	Milpharm Limited	subsidiary	Interest received			Not Applicable			79.60	87.10	36.20
397	Aurobindo Pharma B.V.	Arrow generiques SAS	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.20	0.00	0.00
398	Aurobindo Pharma B.V.	Aurovitas Nederland B.V	subsidiary	Interest received			Not Applicable			230.70	0.00	0.00
399	Aurobindo Pharma B.V.	Aurovitas Nederland B.V	subsidiary	Loan			Not Applicable			0.00	10,640.90	14,831.20
400	Aurobindo Pharma B.V.	Aurobindo Pharma (Italia) S.r.l	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.10	1.60	0.00
401	Aurobindo Pharma B.V.	Agile Pharma B.V.	subsidiary	Interest received			Not Applicable			261.90	407.50	59.30
402	Aurobindo Pharma B.V.	Agile Pharma B.V.	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			4.50	0.00	0.00
403	Aurobindo Pharma B.V.	Agile Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	27,063.00	33,180.00
404	Aurobindo Pharma B.V.	Agile Pharma B.V.	subsidiary	Any other transaction	Trade Receivable		Not Applicable			0.00	0.20	0.00
405	Aurobindo Pharma B.V.	Puren Pharma GmbH & Co., KG	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.30	0.00	0.00
406	Aurobindo Pharma B.V.	Aurovitas Pharma Polska	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			3.50	0.00	0.00
407	Aurovitas Nederland B.V	Aurobindo Pharma B.V.	subsidiary	Interest received			Not Applicable			2.80	1.80	0.00
408	Aurovitas Nederland B.V	Aurobindo Pharma B.V.	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			8.30	0.00	0.00
409	Aurovitas Nederland B.V	Aurobindo Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	286.90	59.90
410	Aurovitas Spol s.r.o	Aurobindo Pharma (Italia) S.r.l	subsidiary	Interest received			Not Applicable			36.10	23.40	24.50
411	Aurovitas Spol s.r.o	Aurobindo Pharma (Italia) S.r.l	subsidiary	Loan			Not Applicable			0.00	2,695.10	2,787.70
412	Aurovitas Spol s.r.o	Agile Pharma B.V.	subsidiary	Interest received			Not Applicable			42.90	137.70	7.40
413	Aurovitas Spol s.r.o	Agile Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	2,940.10	3,041.10
414	CuraTeQ Biologics s.r.o.	CuraTeQ Biologics Private Limited	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	270.80	280.30
415	Apotex Europe B.V.	Aurovitas Pharma Polska	subsidiary	Any other transaction	Trade Receivable		Not Applicable			0.00	4.90	0.00
416	Apotex Europe B.V.	Aurovitas Pharma Polska	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			78.40	0.00	0.00
417	Apotex Europe B.V.	Aurobindo Pharma B.V.	subsidiary	Interest received			Not Applicable			59.10	51.90	0.30
418	Apotex Europe B.V.	Aurobindo Pharma B.V.	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.40	0.00	0.00
419	Apotex Europe B.V.	Aurobindo Pharma B.V.	subsidiary	Loan			Not Applicable			0.00	3,849.50	4,130.90
420	Apotex Europe B.V.	APL Swift Services (Malta) Ltd	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			11.10	0.00	11.80
421	TheraNyM Biologics Private Limited	CuraTeQ Biologics Private Limited	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	0.00	7.90
422	CuraTeQ Biologics Private Limited	TheraNyM Biologics Private Limited	subsidiary	Sale of goods or services			Not Applicable			266.70	22.20	262.20
423	CuraTeQ Biologics Private Limited	Auro Vaccines Private Limited	subsidiary	Interest received			Not Applicable			42.80	0.00	0.00
424	CuraTeQ Biologics Private Limited	Auro Vaccines Private Limited	subsidiary	Loan			Not Applicable			0.00	0.00	1,924.20
425	CuraTeQ Biologics Private Limited	Acrotech Biopharma Inc.	subsidiary	Sale of goods or services			Not Applicable			0.00	879.50	939.40
426	CuraTeQ Biologics Private Limited	APL Swift Services (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			125.30	93.00	55.90
427	Aurobindo NV/SA	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			169.80	0.00	34.20
428	Aurobindo NV/SA	Eugia Pharma (Malta) Limited	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			28.30	0.00	7.70
429	Aurobindo NV/SA	Aurovitas Pharma Polska	subsidiary	Sale of goods or services			Not Applicable			0.00	0.00	0.00
430	Aurobindo NV/SA	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			12.80	0.00	8.60
431	Aurobindo NV/SA	Aurovitas Spain SA	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.00	0.00	0.00
432	Aurobindo NV/SA	Aurobindo Pharma (Italia) S.r.l	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.90	0.00	0.00
433	Aurobindo NV/SA	Generis Farmaceutica S.A.	subsidiary	Any other transaction	Trade Receivable		Not Applicable			0.00	0.00	0.90
434	Eugia Pharma Industria Farmaceutica Limitada	Eugia SEZ Private Limited	subsidiary	Sale of goods or services			Not Applicable			0.00	11.70	12.40
435	Eugia Pharma Industria Farmaceutica Limitada	Eugia Pharma Specialities Ltd	subsidiary	Sale of goods or services			Not Applicable			12.20	0.00	13.60
436	Eugia Pharma (Malta) Limited	Aurovitas Pharma Polska	subsidiary	Sale of goods or services			Not Applicable			500.50	94.20	0.00
437	Eugia Pharma (Malta) Limited	APL Swift Services (Malta) Ltd	subsidiary	Interest received			Not Applicable			17.40	132.70	156.40
438	Eugia Pharma (Malta) Limited	APL Swift Services (Malta) Ltd	subsidiary	Loan			Not Applicable			0.00	1,119.40	2,648.60
439	Eugia Pharma (Malta) Limited	Aurobindo Pharma (Italia) S.r.l	subsidiary	Sale of goods or services			Not Applicable			4,172.10	1,694.10	1,460.10
440	Eugia Pharma (Malta) Limited	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			6,159.10	3,005.30	3,673.90
441	Eugia Pharma (Malta) Limited	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			10,374.40	4,532.90	5,964.10
442	Eugia Pharma (Malta) Limited	Puren Pharma GmbH & Co., KG	subsidiary	Sale of goods or services			Not Applicable			5,536.60	1,813.60	1,226.60
443	Eugia Pharma (Malta) Limited	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			13,822.40	7,385.20	5,592.80
444	Eugia Pharma (Malta) Limited	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Not Applicable			1,781.00	1,143.00	667.60
445	Eugia Pharma (Malta) Limited	Aurobindo NV/SA	subsidiary	Sale of goods or services			Not Applicable			409.90	363.20	79.20
446	Eugia Pharma (Malta) Limited	Eugia Pharma Specialities Ltd	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			123.10	0.00	0.00
447	Eugia Pharma B.V.	Eugia Pharma (Malta) Limited	subsidiary	Dividend received			Not Applicable			3,959.60	3,042.60	7,392.20
448	Eugia Pharma B.V.	APL Swift Services (Malta) Ltd	subsidiary	Loan			Not Applicable			0.00	0.00	1,743.90
449	Eugia Pharma B.V.	APL Swift Services (Malta) Ltd	subsidiary	Interest received			Not Applicable			10.30	0.00	10.90
450	Eugia (UK) Limited	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			170.10	4.80	44.70
451	CuraTeQ Biologics (Malta) Limited	CuraTeQ Biologics B.V., Netherlands	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	0.00	1.30
452	Ace Laboratories Limited	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			621.00	71.70	47.40
453	Aurobindo Pharma Industria Farmaceutica Ltd	Eugia Pharma Industria Farmaceutica Limitada	subsidiary	Any other transaction	Rent received		Not Applicable			25.30	0.00	0.00
454	Aurobindo Pharma Industria Farmaceutica Ltd	CuraTeQ Biologics Private Limited	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			4.00	24.60	3.30
455	All Pharma (Shanghai) Trading Co Ltd	APL Healthcare Limited	subsidiary	Sale of goods or services			Not Applicable			0.30	7.90	8.70
456	All Pharma (Shanghai) Trading Co Ltd	Auro Peptides Ltd	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	7.50	8.10
457	All Pharma (Shanghai) Trading Co Ltd	Lyfius Pharma Private Limited	subsidiary	Any other transaction	Other Receivable		Not Applicable			83.10	59.20	71.60
458	All Pharma (Shanghai) Trading Co Ltd	Eugia Pharma Specialities Ltd	subsidiary	Any other transaction	Other Receivable		Not Applicable			5.10	32.70	40.50
459	All Pharma (Shanghai) Trading Co Ltd	Aurovitas Pharma (Taizhou) Ltd	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	1,698.40	1,882.50
460	Aurovitas Pharma (Taizhou) Ltd	Auro Peptides Ltd	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			0.00	45.80	50.40
461	Aurovitas Pharma (Taizhou) Ltd	APL Swift Services (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			3,075.70	1,426.40	3,401.40
462	Aurovitas Pharma (Taizhou) Ltd	All Pharma (Shanghai) Trading Co Ltd	subsidiary	Sale of goods or services			Not Applicable			124.20	273.20	300.70
463	Aurovitas Pharma (Taizhou) Ltd	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			1,809.60	937.30	541.10
464	Auro Pharma Inc.	Eugia Pharma INC, Canada	subsidiary	Any other transaction	Miscellaneous Income		Not Applicable			464.50	386.60	351.00
465	Auro Pharma Inc.	CuraTeQ Biologics Private Limited	subsidiary	Any other transaction	Trade Receivable		Not Applicable			0.00	14.20	15.10
466	Auro Pharma Inc.	Eugia Pharma Specialities Ltd	subsidiary	Sale of goods or services			Not Applicable			15.80	0.00	0.00
467	Auro Pharma Inc.	Aurobindo Pharma USA Inc.	subsidiary	Any other transaction	other income		Not Applicable			1.00	0.00	1.10
468	Aurobindo Pharma Saudi Arabia Limited Company	Aurobindo Pharma FZ-LLC	subsidiary	Interest received			Not Applicable			63.90	11.00	78.80
469	Aurobindo Pharma Saudi Arabia Limited Company	Aurobindo Pharma FZ-LLC	subsidiary	Loan			Not Applicable			0.00	2,663.40	2,842.90
470	Aurobindo Pharma FZ-LLC	Aurovitas Pharma (Taizhou) Ltd	subsidiary	Interest received			Not Applicable			42.70	124.50	177.90
471	Aurobindo Pharma FZ-LLC	PT Aurogen Pharma Indonesia	subsidiary	Sale of goods or services			Not Applicable			7,150.60	0.00	3,645.20
472	Aurobindo Pharma FZ-LLC	PT Aurogen Pharma Indonesia	subsidiary	Interest received			Not Applicable			101.00	49.50	159.00
473	Aurobindo Pharma FZ-LLC	PT Aurogen Pharma Indonesia	subsidiary	Loan			Not Applicable			0.00	3,992.50	7,344.60
474	Aurobindo Pharma FZ-LLC	Aurovitas Pharma (Taizhou) Ltd	subsidiary	Loan			Not Applicable			0.00	1,774.40	1,895.40
475	Lyfius Pharma Private Limited	Qule Pharma Private Limited	subsidiary	Sale of goods or services			Not Applicable			1,066.70	0.00	0.00
476	Lyfius Pharma Private Limited	Qule Pharma Private Limited	subsidiary	Sale of goods or services			Not Applicable			57,147.00	11,400.20	27,431.70
477	Lyfius Pharma Private Limited	Qule Pharma Private Limited	subsidiary	Sale of fixed assets			Not Applicable			0.00	0.00	0.00
478	Aurobindo Pharma (Pty) Ltd	Aurogen South Africa (PTY) Ltd	subsidiary	Sale of goods or services			Not Applicable			54.30	261.80	0.40
479	Aurogen South Africa (PTY) Ltd	Aurobindo Pharma (Pty) Ltd	subsidiary	Sale of goods or services			Not Applicable			1.30	12.00	0.90
480	Aurosalud SA De CV	Aurovida Farmaceutica SA DE CV	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	0.00	7,547.70
481	Aurobindo Pharma Colombia S A S	Aurovida Farmaceutica SA DE CV	subsidiary	Sale of goods or services			Not Applicable			0.00	100.30	106.50
482	Aurobindo Pharma Colombia S A S	Eugia Pharma Colombia S.A.S.	subsidiary	Sale of goods or services			Not Applicable			343.00	1,648.50	1,928.10
483	Eugia Pharma Colombia S.A.S.	Aurobindo Pharma Colombia S A S	subsidiary	Sale of goods or services			Not Applicable			1.60	22.60	0.00
484	Aurogen South Africa (PTY) Ltd	Purple Bellflower, South Africa	subsidiary	Loan			Not Applicable			0.00	5.20	5.60
485	Eugia Pharma (Australia) PTY Limited	Eugia Pharma Specialities Ltd	subsidiary	Sale of goods or services			Not Applicable			542.50	0.00	603.50
486	Eugia Pharma (Australia) PTY Limited	Eugia SEZ Private Limited	subsidiary	Sale of goods or services			Not Applicable			13.00	0.00	14.50
487	Aurobindo Pharma USA Inc.	Auro PR Inc	subsidiary	Sale of goods or services			Not Applicable			5.00	10.00	15.80
488	Aurobindo Pharma USA Inc.	Eugia US Manufacturing LLC	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			(5.80)	0.00	0.40
489	Aurobindo Pharma USA Inc.	Eugia US LLC	subsidiary	Sale of goods or services			Not Applicable			97.00	27.20	64.70
490	Aurobindo Pharma USA Inc.	Eugia US LLC	subsidiary	Any other transaction	Rent received		Not Applicable			51.60	0.00	0.00
491	Aurobindo Pharma USA Inc.	Eugia US LLC	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			230.40	0.00	0.00
492	Aurobindo Pharma USA Inc.	Auro Pharma Inc.	subsidiary	Sale of goods or services			Not Applicable			0.60	0.00	0.00
493	Aurobindo Pharma USA Inc.	TheraNyM Biologics Private Limited	subsidiary	Any other transaction	Trade Receivable		Not Applicable			0.00	475.20	0.00
494	Aurobindo Pharma USA Inc.	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			156.20	72.70	84.40
495	Aurolife Pharma LLC	APL Healthcare Limited	subsidiary	Sale of goods or services			Not Applicable			0.00	437.30	268.50
496	Aurolife Pharma LLC	Aurovitas Pharma (Taizhou) Ltd	subsidiary	Sale of fixed assets			Not Applicable			9.20	425.20	454.20
497	Auro Health LLC	APL Healthcare Limited	subsidiary	Sale of goods or services			Not Applicable			0.00	2.70	2.80
498	Acrotech Biopharma Inc.	Auro PR Inc	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			4.60	12.00	17.50
499	AuroLogistics LLC	Eugia US LLC	subsidiary	Sale of goods or services			Not Applicable			1,687.50	271.90	557.20
500	Eugia US Manufacturing LLC	Eugia Pharma Specialities Ltd	subsidiary	Sale of fixed assets			Not Applicable			78.40	0.00	0.00
501	Eugia US Manufacturing LLC	Aurobindo Pharma USA Inc.	subsidiary	Any other transaction	Other Receivable		Not Applicable			2.20	3.40	0.00
502	Eugia US LLC	Aurobindo Pharma Colombia S A S	subsidiary	Sale of goods or services			Not Applicable			(4.20)	4.30	0.00
503	Eugia US LLC	Eugia Pharma Specialities Ltd	subsidiary	Any other transaction	Other Receivable		Not Applicable			135.90	0.00	145.10
504	Eugia US LLC	Eugia Pharma INC, Canada	subsidiary	Sale of goods or services			Not Applicable			33.30	0.00	35.80
505	Qule Pharma Private Limited	Lyfius Pharma Private Limited	subsidiary	Any other transaction	Miscellaneous Income		Not Applicable			0.50	0.00	0.00
506	Qule Pharma Private Limited	Lyfius Pharma Private Limited	subsidiary	Sale of goods or services			Not Applicable			2,617.80	191.80	122.60
507	Qule Pharma Private Limited	Lyfius Pharma Private Limited	subsidiary	Sale of fixed assets			Not Applicable			0.00	0.00	0.00
508	APL Healthcare Limited	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			85.80	6.70	9.50
509	APL Healthcare Limited	APL Swift Services (Malta) Ltd	subsidiary	Sale of goods or services			Not Applicable			7,063.40	8,865.50	11,976.10
510	APL Healthcare Limited	Generis Farmaceutica S.A.	subsidiary	Sale of goods or services			Not Applicable			89.60	51.90	29.00
511	APL Healthcare Limited	Arrow generiques SAS	subsidiary	Sale of goods or services			Not Applicable			24.40	19.80	28.20
512	APL Healthcare Limited	Aurovitas Spain SA	subsidiary	Sale of goods or services			Not Applicable			22.00	0.00	23.70
513	APL Healthcare Limited	Aurobindo Pharma B.V.	subsidiary	Sale of goods or services			Not Applicable			2,135.10	3,384.40	2,041.90
514	APL Healthcare Limited	Auro Pharma Inc.	subsidiary	Sale of goods or services			Not Applicable			6,920.50	2,868.00	8,618.40
515	APL Healthcare Limited	Aurobindo Pharma (Pty) Ltd	subsidiary	Sale of goods or services			Not Applicable			20,905.10	7,891.60	22,909.30
516	APL Healthcare Limited	Aurovida Farmaceutica SA DE CV	subsidiary	Sale of goods or services			Not Applicable			4,046.10	497.90	4,848.60
517	APL Healthcare Limited	Aurogen South Africa (PTY) Ltd	subsidiary	Sale of goods or services			Not Applicable			12,230.70	8,555.40	9,587.70
518	APL Healthcare Limited	Aurobindo Pharma FZ-LLC	subsidiary	Sale of goods or services			Not Applicable			54.30	80.50	146.10
519	APL Healthcare Limited	Aurobindo Pharma USA Inc.	subsidiary	Sale of goods or services			Not Applicable			95,204.00	89,377.80	70,803.00
520	APL Healthcare Limited	Auro Health LLC	subsidiary	Sale of goods or services			Not Applicable			10,908.50	8,670.30	7,926.00
521	APL Healthcare Limited	Vespyr Brands LLC	subsidiary	Sale of goods or services			Not Applicable			629.80	665.40	1,028.90
522	APL Healthcare Limited	Eugia SEZ Private Limited	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			184.30	61.60	1.20
523	APL Healthcare Limited	Qule Pharma Private Limited	subsidiary	Sale of fixed assets			Not Applicable			16.40	0.00	0.00
524	Auro Peptides Ltd	Eugia Pharma Specialities Ltd	subsidiary	Sale of goods or services		1,500.00	Not Applicable	320.50	09-02-2026	868.20	353.50	99.90
525	Auro Peptides Ltd	GLS Pharma Limted	subsidiary	Sale of goods or services			Not Applicable			127.40	47.80	94.00
526	Auro Peptides Ltd	Aurovitas Pharma (Taizhou) Ltd	subsidiary	Sale of goods or services			Not Applicable			0.00	49.70	53.10
527	Auro Peptides Ltd	TheraNyM Biologics Private Limited	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	0.30	0.00
528	Auro Vaccines LLC	Auro Vaccines Private Limited	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			6.30	87.20	36.70
529	Auro Vaccines Private Limited	CuraTeQ Biologics Private Limited	subsidiary	Sale of goods or services			Not Applicable			1.90	1.60	0.00
530	Auro Vaccines Private Limited	CuraTeQ Biologics Private Limited	subsidiary	Sale of fixed assets			Not Applicable			0.00	0.00	0.00
531	Auro Vaccines Private Limited	TheraNyM Biologics Private Limited	subsidiary	Any other transaction	Other Receivable		Not Applicable			0.00	1.60	0.00
532	Auro Vaccines Private Limited	Eugia SEZ Private Limited	subsidiary	Sale of fixed assets			Not Applicable			1,135.70	0.00	1,134.60
533	Eugia Steriles Private Limited	Eugia Pharma Specialities Ltd	subsidiary	Sale of goods or services			Not Applicable			299.20	49.40	147.60
534	Eugia Steriles Private Limited	Eugia US LLC	subsidiary	Sale of goods or services			Not Applicable			207.60	0.00	31.30
535	Eugia SEZ Private Limited	APL Healthcare Limited	subsidiary	Sale of goods or services			Not Applicable			(160.90)	0.00	0.00
536	Eugia SEZ Private Limited	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			447.30	1,112.40	484.00
537	Eugia SEZ Private Limited	Aurogen South Africa (PTY) Ltd	subsidiary	Sale of goods or services			Not Applicable			558.10	636.30	544.40
538	Eugia SEZ Private Limited	Aurobindo Pharma FZ-LLC	subsidiary	Sale of goods or services			Not Applicable			102.50	170.70	111.50
539	Eugia SEZ Private Limited	Eugia Pharma (Australia) PTY Limited	subsidiary	Sale of goods or services			Not Applicable			54.70	58.90	121.90
540	Eugia SEZ Private Limited	Eugia Pharma (Malta) Limited	subsidiary	Sale of goods or services			Not Applicable			3,923.60	2,671.00	2,290.80
541	Eugia SEZ Private Limited	Eugia Pharma Industria Farmaceutica Limitada	subsidiary	Sale of goods or services			Not Applicable			2,232.90	1,693.50	1,072.80
542	Eugia SEZ Private Limited	Eugia Pharma Colombia S.A.S.	subsidiary	Sale of goods or services			Not Applicable			503.90	0.00	546.50
543	Eugia SEZ Private Limited	Eugia US LLC	subsidiary	Sale of goods or services			Not Applicable			13,200.30	7,943.20	8,011.70
544	Eugia Pharma Specialities Ltd	Eugia SEZ Private Limited	subsidiary	Sale of goods or services			Not Applicable			0.30	25.10	4.60
545	Eugia Pharma Specialities Ltd	Eugia SEZ Private Limited	subsidiary	Sale of fixed assets			Not Applicable			9.30	0.00	0.00
546	Eugia Pharma Specialities Ltd	Auro Pharma Inc.	subsidiary	Sale of goods or services			Not Applicable			2,828.50	1,607.80	3,340.80
547	Eugia Pharma Specialities Ltd	APL Pharma Thai Limited	subsidiary	Sale of goods or services			Not Applicable			1,120.20	325.80	538.30
548	Eugia Pharma Specialities Ltd	Eugia Pharma (Australia) PTY Limited	subsidiary	Sale of goods or services			Not Applicable			224.70	349.50	371.50
549	Eugia Pharma Specialities Ltd	Eugia Pharma INC, Canada	subsidiary	Sale of goods or services			Not Applicable			3,371.30	5,932.20	4,619.10
550	Eugia Pharma Specialities Ltd	Eugia Pharma (Malta) Limited	subsidiary	Sale of goods or services			Not Applicable			20,707.70	8,293.50	9,518.40
551	Eugia Pharma Specialities Ltd	Eugia Pharma Industria Farmaceutica Limitada	subsidiary	Sale of goods or services			Not Applicable			4,629.40	1,761.60	2,498.50
552	Eugia Pharma Specialities Ltd	Aurobindo Pharma Colombia S A S	subsidiary	Sale of goods or services			Not Applicable			63.90	145.70	64.20
553	Eugia Pharma Specialities Ltd	Eugia Pharma Colombia S.A.S.	subsidiary	Sale of goods or services			Not Applicable			749.30	1,971.10	1,390.70
554	Eugia Pharma Specialities Ltd	Aurovida Farmaceutica SA DE CV	subsidiary	Sale of goods or services			Not Applicable			3,329.40	5,880.60	7,619.00
555	Eugia Pharma Specialities Ltd	Aurogen South Africa (PTY) Ltd	subsidiary	Sale of goods or services			Not Applicable			1,904.80	1,003.60	851.30
556	Eugia Pharma Specialities Ltd	Aurobindo Pharma FZ-LLC	subsidiary	Sale of goods or services			Not Applicable			0.00	27.50	0.00
557	Eugia Pharma Specialities Ltd	Aurobindo Pharma USA Inc.	subsidiary	Sale of goods or services			Not Applicable			33,413.50	11,024.30	20,238.70
558	Eugia Pharma Specialities Ltd	Auro Health LLC	subsidiary	Sale of goods or services			Not Applicable			803.30	374.70	483.00
559	Eugia Pharma Specialities Ltd	Acrotech Biopharma Inc.	subsidiary	Sale of goods or services			Not Applicable			10.00	0.00	0.00
560	Eugia Pharma Specialities Ltd	Eugia US LLC	subsidiary	Sale of goods or services			Not Applicable			60,651.40	24,835.90	15,346.90
561	Eugia Pharma Specialities Ltd	Milpharm Limited	subsidiary	Sale of goods or services			Not Applicable			665.70	492.50	875.50
562	Eugia Pharma Specialities Ltd	Eugia Steriles Private Limited	subsidiary	Sale of goods or services			Not Applicable			0.00	791.20	19.80
563	Eugia Pharma Specialities Ltd	Eugia Steriles Private Limited	subsidiary	Interest received			Not Applicable			507.20	516.80	948.70
564	Eugia Pharma Specialities Ltd	Eugia Steriles Private Limited	subsidiary	Any other transaction	Miscellaneous Income		Not Applicable			19.50	0.00	0.00
565	Eugia Pharma Specialities Ltd	Eugia Steriles Private Limited	subsidiary	Loan			Not Applicable			0.00	11,000.00	14,900.00
566	Eugia Pharma Specialities Ltd	GLS Pharma Limted	subsidiary	Sale of goods or services			Not Applicable			15.30	0.00	15.30
567	Eugia Pharma Specialities Ltd	Auro Peptides Ltd	subsidiary	Sale of goods or services			Not Applicable			0.00	0.00	0.00
568	CuraTeQ Biologics B.V., Netherlands	CuraTeQ Biologics s.r.o.	subsidiary	Interest received			Not Applicable			3.30	0.00	3.50
569	CuraTeQ Biologics B.V., Netherlands	CuraTeQ Biologics s.r.o.	subsidiary	Loan			Not Applicable			0.00	0.00	1,090.00
570	CuraTeQ Biologics B.V., Netherlands	APL Swift Services (Malta) Ltd	subsidiary	Loan			Not Applicable			0.00	0.00	3,269.90
571	CuraTeQ Biologics B.V., Netherlands	APL Swift Services (Malta) Ltd	subsidiary	Interest received			Not Applicable			3.70	0.00	3.90
572	Agile Pharma B.V.	Milpharm Limited	subsidiary	Dividend received			Not Applicable			26.60	0.00	0.00
573	Auroactive Pharma Private limited	APL Healthcare Limited	subsidiary	Sale of goods or services			Not Applicable			345.90	230.60	449.80
574	Auroactive Pharma Private limited	Lyfius Pharma Private Limited	subsidiary	Sale of goods or services			Not Applicable			0.00	8.00	0.00
575	Auroactive Pharma Private limited	Lyfius Pharma Private Limited	subsidiary	Sale of fixed assets			Not Applicable			66.80	0.00	66.80
576	Auroactive Pharma Private limited	Qule Pharma Private Limited	subsidiary	Sale of fixed assets			Not Applicable			113.40	0.00	113.30
577	Aurolife Pharma LLC	Eugia US Manufacturing LLC	subsidiary	Any other transaction	Trade Receivable		Not Applicable			0.00	255.10	272.50
578	Eugia Pharma Specialities Ltd	Eugia Steriles Private Limited	subsidiary	Investment			Not Applicable			13,000.00	0.00	0.00
579	CuraTeQ Biologics Private Limited	Auro Vaccines Private Limited	subsidiary	Investment			Not Applicable			52,811.70	0.00	0.00
580	CuraTeQ Biologics Private Limited	CuraTeQ Biologics B.V., Netherlands	subsidiary	Investment			Not Applicable			4,535.00	0.00	0.00
581	CuraTeQ Biologics B.V., Netherlands	CuraTeQ Biologics s.r.o.	subsidiary	Investment			Not Applicable			315.90	0.00	0.00
582	CuraTeQ Biologics B.V., Netherlands	CuraTeQ Biologics (Malta) Limited	subsidiary	Investment			Not Applicable			1.30	0.00	0.00
583	Helix Healthcare B.V.	PT Aurogen Pharma Indonesia	subsidiary	Investment			Not Applicable			5,492.10	0.00	0.00
584	Helix Healthcare B.V.	Aurobindo Pharma (Malaysia) SDN. BHD.	subsidiary	Investment			Not Applicable			18.10	0.00	0.00
585	Arrow generiques SAS	Diadame Pharma	subsidiary	Investment			Not Applicable			581.10	0.00	0.00
586	Eugia Pharma B.V.	Eugia Pharma (Australia) PTY Limited	subsidiary	Investment			Not Applicable			0.00	0.00	0.00
587	Aurobindo Pharma USA Inc.	AuroLogistics LLC	subsidiary	Sale of goods or services			Not Applicable			1,685.20	0.00	0.00
588	Aurobindo Pharma USA Inc.	Acrotech Biopharma Inc.	subsidiary	Any other transaction	Reimbursement of expenses received		Not Applicable			1,484.90	0.00	0.00
589	Aurobindo Pharma USA Inc.	Aurolife Pharma LLC	subsidiary	Sale of goods or services			Not Applicable			2.60	0.00	0.00
590	Aurobindo Pharma USA Inc.	Auro Health LLC	subsidiary	Loan			Not Applicable			0.00	29,368.80	26,701.00
591	Aurolife Pharma LLC	Aurobindo Pharma USA Inc.	subsidiary	Sale of goods or services			Not Applicable			5,064.30	1,272.70	1,582.30
592	Aurolife Pharma LLC	Aurobindo Pharma USA Inc.	subsidiary	Any other transaction	Rent received		Not Applicable			159.70	0.00	0.00
593	Aurolife Pharma LLC	Auro Health LLC	subsidiary	Sale of goods or services			Not Applicable			8.20	0.00	0.00
594	Auro Health LLC	Aurobindo Pharma USA Inc.	subsidiary	Sale of goods or services			Not Applicable			1,326.50	662.50	1,079.10
595	Auro Health LLC	Vespyr Brands LLC	subsidiary	Loan			Not Applicable			0.00	50,228.30	52,505.20
596	Auro Health LLC	Vespyr Brands LLC	subsidiary	Sale of goods or services			Not Applicable			39.70	0.00	0.00
597	AuroLogistics LLC	Aurobindo Pharma USA Inc.	subsidiary	Sale of goods or services			Not Applicable			10,875.30	0.00	0.00
598	AuroLogistics LLC	Auro Health LLC	subsidiary	Sale of goods or services			Not Applicable			1,958.30	0.00	0.00
599	Auro Packaging LLC	Auro Health LLC	subsidiary	Sale of goods or services			Not Applicable			940.50	0.00	0.00
600	Auro Packaging LLC	Vespyr Brands LLC	subsidiary	Sale of goods or services			Not Applicable			16.20	0.00	0.00
601	Eugia US LLC	Eugia US Manufacturing LLC	subsidiary	Loan			Not Applicable			0.00	2,656.40	0.00
602	APL Healthcare Limited	Aurobindo Pharma Foundation	subsidiary	Any other transaction	Contribution to CSR		Not Applicable			1,425.40	0.00	0.00
603	Eugia Pharma Specialities Ltd	Aurobindo Pharma Foundation	subsidiary	Any other transaction	Contribution to CSR		Not Applicable			1,736.00	0.00	0.00
604	GLS Pharma Limted	East Pharma Technologies	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
605	APL Healthcare Limited	Alcedo Pharmachem Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			1,462.30	428.20	537.80
606	APL Healthcare Limited	East Pharma Technologies	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			236.90	10.50	107.40
607	APL Healthcare Limited	Gelcaps�Industries	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			2,729.00	1,316.90	868.00
608	APL Healthcare Limited	Orem Access Bio Inc	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			874.10	133.10	268.00
609	APL Healthcare Limited	Pranit Packaging Pvt.Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	6.00	0.00
610	APL Healthcare Limited	Pravesha Industries Pvt. Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
611	APL Healthcare Limited	Sri Sai Packaging Works	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			190.00	41.70	58.20
612	APL Healthcare Limited	Valucor Packaging Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			596.20	278.20	234.00
613	CuraTeQ Biologics Private Limited	Axis Clinicals Ltd	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		16,500.00	Not Applicable			(412.10)	0.00	2,623.30
614	CuraTeQ Biologics Private Limited	East Pharma Technologies	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		20.00	Not Applicable			0.80	0.00	0.00
615	CuraTeQ Biologics Private Limited	Sri Sai Packaging Works	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
616	CuraTeQ Biologics Private Limited	Pranit Packaging Pvt.Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.50	0.00	0.00
617	CuraTeQ Biologics Private Limited	Pravesha Industries Pvt. Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
618	CuraTeQ Biologics Private Limited	Auro Enterprises (India) Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		430.00	Not Applicable			0.00	0.00	0.00
619	CuraTeQ Biologics Private Limited	Transaction Square LLP	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			11.90	0.00	0.00
620	CuraTeQ Biologics Private Limited	Valucor Packaging Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.80	0.00	0.00
621	CuraTeQ Biologics Private Limited	Satakarni Makkapati	Enterprises over which key managerial personnel or their relatives exercise significant influence	Any other transaction	Issue of Compulsorily Convertible Preference Shares		Not Applicable			227.30	0.00	0.00
622	Eugia Steriles Private Limited	Pranit Packaging Pvt.Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		100.00	Not Applicable			3.40	1.30	0.00
623	Eugia Steriles Private Limited	Pravesha Industries Pvt. Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			8.90	0.00	0.80
624	Eugia Steriles Private Limited	Valucor Packaging Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			3.20	0.00	2.50
625	Eugia Steriles Private Limited	Auro Enterprises (India) Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		540.00	Not Applicable			23.90	1.80	3.30
626	Eugia Steriles Private Limited	Sri Sai Packaging Works	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			5.10	0.90	0.00
627	Eugia Steriles Private Limited	East Pharma Technologies	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		150.00	Not Applicable			89.80	7.90	13.20
628	Lyfius Pharma Private Limited	Kakinada SEZ Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
629	Lyfius Pharma Private Limited	Kakinada SEZ Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Advance			Not Applicable			0.00	666.60	676.20
630	Lyfius Pharma Private Limited	Sri Sai Packaging Works	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			44.20	0.30	43.00
631	Lyfius Pharma Private Limited	East Pharma Technologies	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.60	0.00	0.60
632	Lyfius Pharma Private Limited	Auro Enterprises (India) Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		40,500.00	Not Applicable			13,292.60	0.00	307.20
633	Lyfius Pharma Private Limited	Auro Enterprises (India) Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Advance			Not Applicable			0.00	1,132.30	0.00
634	Lyfius Pharma Private Limited	Shreas industries limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		2,400.00	Not Applicable			1,325.10	235.40	488.30
635	Lyfius Pharma Private Limited	Kakinada Gateway Port Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			1.50	0.00	0.00
636	Lyfius Pharma Private Limited	Kakinada Gateway Port Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Advance			Not Applicable			0.00	1.90	0.10
637	Qule Pharma Private Limited	Kakinada SEZ Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			1,838.50	0.00	0.00
638	Qule Pharma Private Limited	Kakinada SEZ Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Advance			Not Applicable			0.00	366.00	184.90
639	Qule Pharma Private Limited	Shreas Industries Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		2,300.00	Not Applicable			290.70	0.00	64.00
640	Qule Pharma Private Limited	Shreas Industries Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of fixed assets			Not Applicable			0.00	0.00	0.00
641	Qule Pharma Private Limited	Sri Sai Packaging Works	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			52.90	0.20	0.00
642	Qule Pharma Private Limited	Pranit Packaging Pvt Ltd	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.10	0.00	0.10
643	Auroactive Pharma Private limited	Sri Sai Packaging Works	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		90.00	Not Applicable	40.00	31-03-2026	65.70	0.20	23.40
644	Auroactive Pharma Private limited	Pravesha Industries Pvt. Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
645	Auroactive Pharma Private limited	Pranit Packaging Pvt.Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.10	0.00	0.00
646	Auroactive Pharma Private limited	Auro Enterprises (India) Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		6,600.00	Not Applicable			286.00	106.50	17.00
647	Auroactive Pharma Private limited	Shreas Industries Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services		4,900.00	Not Applicable			612.40	166.50	201.90
648	Auroactive Pharma Private limited	Shreas Industries Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Sale of goods or services			Not Applicable			2.70	0.00	0.00
649	Eugia SEZ Private Limited	East Pharma Technologies	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			183.60	52.30	32.50
650	Eugia SEZ Private Limited	Pranit Packaging Pvt.Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			24.80	14.10	0.00
651	Eugia SEZ Private Limited	Pravesha Industries Pvt. Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			209.10	0.00	88.00
652	Eugia SEZ Private Limited	Valucor Packaging Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			58.00	0.00	17.30
653	Eugia SEZ Private Limited	Sri Sai Packaging Works	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			6.00	1.50	0.00
654	Eugia Pharma Specialities Ltd	East Pharma Technologies	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			732.10	88.10	179.70
655	Eugia Pharma Specialities Ltd	Orem Access Bio Inc	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			8.70	0.00	3.50
656	Eugia Pharma Specialities Ltd	Pranit Packaging Pvt.Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			39.60	40.70	0.00
657	Eugia Pharma Specialities Ltd	Pravesha Industries Pvt. Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			1,100.20	0.00	500.90
658	Eugia Pharma Specialities Ltd	Valucor Packaging Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			148.60	0.00	63.20
659	Eugia Pharma Specialities Ltd	Sri Sai Packaging Works	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			28.20	4.60	3.30
660	Eugia Pharma Specialities Ltd	Auro Enterprises (India) Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			301.50	0.00	0.00
661	Eugia Pharma Specialities Ltd	Auro Enterprises (India) Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Advance			Not Applicable			0.00	152.70	173.70
662	Eugia Pharma Specialities Ltd	Auro Enterprises (India) Private Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			130.00	0.00	0.00
663	Eugia Pharma Specialities Ltd	Trident Chemphar Limited	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	3.50	3.50
664	Eugia Pharma Specialities Ltd	Axis Clinicals Ltd	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			436.30	0.00	41.30
665	Acrotech Biopharma Inc.	Axis Clinicals LLC USA	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			318.50	47.80	265.50
666	Aurobindo Pharma USA Inc.	Axis Clinicals LLC USA	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			304.20	0.00	0.00
667	Aurobindo Pharma USA Inc.	Axis Clinicals Ltd	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			587.20	251.00	127.10
668	Aurobindo Pharma USA Inc.	Luoxin Aurovitas Pharm (Chengdu) Co. Ltd., China	Joint ventures	Purchase of goods or services			Not Applicable			1,425.40	0.00	210.50
669	Aurobindo Pharma USA Inc.	Luoxin Aurovitas Pharm (Chengdu) Co. Ltd., China	Joint ventures	Advance			Not Applicable			0.00	62.90	0.00
670	Aurobindo Pharma USA Inc.	P Venkata Ramprasad Reddy	Key managerial personnel	Remuneration			Not Applicable			170.60	0.00	0.00
671	Auro Peptides Ltd	Sri Sai Packaging Works	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
672	Auro Pharma Inc.	Axis Clinicals Ltd	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			612.80	0.00	0.00
673	Auro vaccines Private Limited	Pranit Packaging Pvt.Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of fixed assets			Not Applicable			0.00	0.00	0.00
674	Auro Health LLC	Pravesha Industries Pvt. Ltd.	Enterprises over which key managerial personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			1.00	0.00	0.00
675	APITORIA PHARMA PRIVATE LIMITED	ALL PHARMA (SHANGHAI) TRADING CO.,LTD	subsidiary	Purchase of goods or services			Not Applicable			35.10	40.90	69.60
676	APITORIA PHARMA PRIVATE LIMITED	APL HEALTH CARE LIMITED	subsidiary	Purchase of goods or services			Not Applicable			5.60	37.50	40.10
677	APITORIA PHARMA PRIVATE LIMITED	ARROW GENERIQUES	subsidiary	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
678	APITORIA PHARMA PRIVATE LIMITED	Auro Infra Private Limited (formerly known as Aurobindo Realty & Infrastructure Pvt. Ltd.)	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
679	APITORIA PHARMA PRIVATE LIMITED	AUROPRO SOFT SYSTEMS PVT. LTD	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			298.20	0.00	0.00
680	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA JAPAN KK	subsidiary	Purchase of goods or services			Not Applicable			0.00	76.80	0.00
681	APITORIA PHARMA PRIVATE LIMITED	EUGIA PHARMA SPECIALITIES LIMITED	subsidiary	Purchase of goods or services			Not Applicable			1,535.80	34.30	18.10
682	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA PRODUTOS FARMACEUTICOS LTDA	subsidiary	Purchase of goods or services			Not Applicable			0.00	7.40	13.90
683	APITORIA PHARMA PRIVATE LIMITED	Eugia SEZ Pvt.Ltd., (Wytells Pharma Pvt.Ltd.,)	subsidiary	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
684	APITORIA PHARMA PRIVATE LIMITED	NVNR (Ramannapet I) Power Plant Private Limited, India	Associate Company	Purchase of goods or services			Not Applicable			101.40	(12.00)	41.80
685	APITORIA PHARMA PRIVATE LIMITED	NVNR (Ramannapet II) Power Plant Private Limited, India	Associate Company	Purchase of goods or services			Not Applicable			341.80	31.10	9.40
686	APITORIA PHARMA PRIVATE LIMITED	Orem Access Bio Inc, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.10	0.00	0.00
687	APITORIA PHARMA PRIVATE LIMITED	Pranit Packaging Private Limited, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			66.30	8.50	0.00
688	APITORIA PHARMA PRIVATE LIMITED	Sri Sai Packaging, India	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			737.30	101.80	158.20
689	APITORIA PHARMA PRIVATE LIMITED	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Purchase of goods or services			Not Applicable			15.10	0.00	7.50
690	APITORIA PHARMA PRIVATE LIMITED	QULE PHARMA PRIVATE LIMITED	subsidiary	Purchase of goods or services			Not Applicable			36,794.20	440.40	5,405.60
691	APITORIA PHARMA PRIVATE LIMITED	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Purchase of goods or services			Not Applicable			68.40	7.80	69.00
692	APITORIA PHARMA PRIVATE LIMITED	Auro Enterprises (India) Private Limited	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			6,828.70	(1,074.40)	(2,745.50)
693	APITORIA PHARMA PRIVATE LIMITED	EAST PHARMA TECHNOLOGIES	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			0.00	0.00	0.00
694	APITORIA PHARMA PRIVATE LIMITED	SHREAS INDUSTRIES LIMITED	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			4,733.80	405.10	1,001.20
695	APITORIA PHARMA PRIVATE LIMITED	VALUCOR PACKAGING PRIVATE LIMITED	Enterprises over which key management personnel or their relatives exercise significant influence	Purchase of goods or services			Not Applicable			71.90	0.00	27.70
696	APITORIA PHARMA PRIVATE LIMITED	AGILE PHARMA BV	subsidiary	Sale of goods or services			Not Applicable			187.40	133.70	44.00
697	APITORIA PHARMA PRIVATE LIMITED	APL HEALTH CARE LIMITED	subsidiary	Sale of goods or services			Not Applicable			56,764.70	27,620.90	26,094.00
698	APITORIA PHARMA PRIVATE LIMITED	ARROW GENERIQUES	subsidiary	Sale of goods or services			Not Applicable			30.30	0.00	0.00
699	APITORIA PHARMA PRIVATE LIMITED	AURO PEPTIDES LIMITED	subsidiary	Sale of goods or services			Not Applicable			23.60	2.90	8.20
700	APITORIA PHARMA PRIVATE LIMITED	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Sale of goods or services			Not Applicable			251.10	14.30	0.10
701	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA (PTY) LTD	subsidiary	Sale of goods or services			Not Applicable			2,534.00	1,380.40	2,437.30
702	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA JAPAN KK	subsidiary	Sale of goods or services			Not Applicable			746.70	649.70	19.70
703	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA USA INC	subsidiary	Sale of goods or services			Not Applicable			0.00	79.90	0.00
704	APITORIA PHARMA PRIVATE LIMITED	AUROVITAS PHARMA TAIZHOU CO. , LTD	subsidiary	Sale of goods or services			Not Applicable			1,448.20	2,836.30	4,580.90
705	APITORIA PHARMA PRIVATE LIMITED	EUGIA PHARMA SPECIALITIES LIMITED	subsidiary	Sale of goods or services			Not Applicable			4,470.30	13,957.30	9,329.90
706	APITORIA PHARMA PRIVATE LIMITED	Eugia SEZ Pvt.Ltd., (Wytells Pharma Pvt.Ltd.,)	subsidiary	Sale of goods or services			Not Applicable			6,723.30	4,221.40	1,995.10
707	APITORIA PHARMA PRIVATE LIMITED	Eugia Sterile Pvt.Ltd., (Auro Cure Pvt.Ltd.,)	subsidiary	Sale of goods or services			Not Applicable			11.50	1,595.00	882.80
708	APITORIA PHARMA PRIVATE LIMITED	GENERIS FARMACEUTICA SA	subsidiary	Sale of goods or services			Not Applicable			318.20	136.20	160.30
709	APITORIA PHARMA PRIVATE LIMITED	Giyaan Pharma Privated Limited, India	Enterprises over which key management personnel or their relatives exercise significant influence	Sale of goods or services			Not Applicable			300.90	485.10	300.90
710	APITORIA PHARMA PRIVATE LIMITED	LYFIUS PHARMA PRIVATE LIMITED	subsidiary	Sale of goods or services			Not Applicable			0.00	26.10	18.70
711	APITORIA PHARMA PRIVATE LIMITED	QULE PHARMA PRIVATE LIMITED	subsidiary	Sale of goods or services			Not Applicable			605.80	417.00	12.10
712	APITORIA PHARMA PRIVATE LIMITED	SHREAS INDUSTRIES LIMITED	Enterprises over which key management personnel or their relatives exercise significant influence	Sale of goods or services			Not Applicable			1.30	5.30	6.60
713	APITORIA PHARMA PRIVATE LIMITED	Sri Sai Packaging, India	Enterprises over which key management personnel or their relatives exercise significant influence	Sale of goods or services			Not Applicable			0.50	0.00	0.00
714	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA PRODUTOS FARMACEUTICA LTDA	subsidiary	Sale of goods or services			Not Applicable			0.00	0.00	0.00
715	APITORIA PHARMA PRIVATE LIMITED	Aurolife Pharma LLC	subsidiary	Any other transaction	Advances from Customers		Not Applicable			9.00	28.30	20.80
716	APITORIA PHARMA PRIVATE LIMITED	QULE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Sale of PPE		Not Applicable			303.50	0.00	0.00
717	APITORIA PHARMA PRIVATE LIMITED	AUROACTIVE PHARMA PRIVATE LIMITED	subsidiary	Any other transaction	Sale of PPE		Not Applicable			0.50	0.00	0.00
718	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA FOUNDATION	subsidiary	Any other transaction	Sale of PPE		Not Applicable			4.40	0.00	0.00
719	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA FOUNDATION	subsidiary	Any other transaction	CSR Contribution		Not Applicable			34.60	0.00	0.00
720	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA PRODUTOS FARMACEUTICA LTDA	subsidiary	Any other transaction	Reimbursement of Expenses		Not Applicable			11.20	0.00	0.00
721	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA (ITALIA) SRL	subsidiary	Any other transaction	Reimbursement of Expenses		Not Applicable			20.70	0.00	10.40
722	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA PRODUTOS FARMACEUTICA LTDA	subsidiary	Any other transaction	Sales Commission		Not Applicable			125.40	0.00	0.00
723	APITORIA PHARMA PRIVATE LIMITED	AUROBINDO PHARMA JAPAN KK	subsidiary	Any other transaction	Sales Commission		Not Applicable			237.90	0.00	0.00
Total value of transaction during the reporting period										18,20,411.50

Integrated Filing — IndAS

General information about company

Financial Results Ind-AS

Amount in (Lakhs)

Disclosure of notes on financial results

Remarks

Statement of Asset and Liabilities

Amount in (Lakhs)

Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Other Comprehensive Income

Amount in (Lakhs)

Cash flow statement, indirect

Amount in (Lakhs)

Details of Impact of Audit Qualification

Amount in (Lakhs)

Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)